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ABSTRACT 
 
Transmission Genetics of Pancreatic Acinar Atrophy in the German Shepherd Dog and 
Development of Microsatellite DNA-based Tools for Canine Forensics and Linkage 
Analysis. (May 2004) 
Leigh Anne Clark, B.S., Texas A&M University 
Co-Chairs of Advisory Committee: Dr. Keith E. Murphy 
                                                       Dr. Jörg M. Steiner 
 
 
The domestic dog, Canis lupus familiaris, has emerged as a model system for the 
study of human hereditary diseases. Of the approximately 450 hereditary diseases 
described in the dog, half have clinical presentations that are quite similar to specific 
human diseases. Understanding the genetic bases of canine hereditary diseases will not 
only complement comparative genetics studies but also facilitate selective breeding 
practices to reduce incidences in the dog. Whole genome screens have great potential to 
identify the marker(s) that segregate with canine hereditary diseases for which no 
reasonable candidate genes exist. The Minimal Screening Set-1 (MSS-1) was the first set 
of microsatellite markers described for linkage analysis in the dog and was, until 
recently, the best tool for genome screens. The MSS-2 is the most recently described 
screening set and offers increased density and more polymorphic markers. The first 
objective of this work was to develop tools to streamline genomic analyses in the study 
of canine hereditary diseases. This was achieved through the development of 1) 
 iv
multiplexing strategies for the MSS-1, 2) a multiplex of microsatellite markers for use in 
canine forensics and parentage assays and 3) chromosome-specific multiplex panels for 
the MSS-2. Multiplexing is the simultaneous amplification and analysis of markers and 
significantly reduces the expense and time required to collect genotype information.  
Pancreatic acinar atrophy (PAA) is a disease characterized by the degeneration of 
acinar cells of the exocrine pancreas and is the most important cause of exocrine 
pancreatic insufficiency (EPI) in the German Shepherd Dog (GSD). Although the 
prognosis for dogs having EPI is typically good with treatment, many dogs are 
euthanized because the owners are unable to afford the expensive enzyme supplements. 
The second objective of this work was to determine the mode of transmission of EPI in 
the GSD and conduct a whole genome screen for linkage. Two extended families of 
GSDs having PAA were assembled and used to determine the pattern of transmission. 
The results of this indicate that PAA is an autosomal recessive disease. The multiplexed 
MSS-1 was used to conduct an initial whole genome screen, although no markers were 
suggestive of linkage. 
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CHAPTER I 
INTRODUCTION 
 
The dog as a model 
In recent years the domestic dog, Canis lupus familiaris, has emerged as a model 
for the study of human hereditary diseases, gene expression, and development. The dog, 
believed to be the first domesticated animal, is in the genus Canis, along with the coyote, 
jackals, and various wolves. All species in this genus are phylogenetically closely related 
and are capable of interbreeding (Wayne and Ostrander 1999). Although it may seem 
that the vast phenotypic diversity of the dog must be the result of multiple founding 
species, current theory holds that the dog diverged exclusively from the wolf, Canis 
lupus. Morphologically, dogs are most similar to Chinese wolves (Wayne and Ostrander 
1999) and recent studies point to an East Asian origin (Savolainen et al. 2002). These 
studies also suggest that a single domestication event occurred roughly 15,000 years ago, 
a date that is consistent with archaeological records that indicate a date of 9,000 to 
14,000 years ago (Savolainen et al. 2002).  
Centuries of selective breeding practices by humans have created more than 300 
breeds of dog, each with its own distinctive morphological and behavioral 
characteristics. It is believed that only a small number of genes is responsible for the 
unique characteristics of each breed. In essence, each breed is an isolated, highly inbred,  
 
_____________________________ 
This dissertation follows the style and format of Mammalian Genome.        
     
 2
young population (most breeds have been developed in the past 250 years) (Ostrander 
and Giniger 1999).  Thus, breeds exhibit substantial interbreed genetic homogeneity and 
remarkable intrabreed phenotypic homogeneity. Factors that have accentuated these 
developments are founder effects, population bottlenecks, and popular sire effects. 
As a consequence of certain breeding practices, more than 450 hereditary 
diseases of the dog have been described to date (OMIA 2003). More than half of these 
diseases have clinical presentations that mimic a specific human hereditary disease, and 
mutations in the same genes are often responsible (Ostrander and Giniger 1997; OMIA 
2003). Unlike rodent models in which mutations are generally induced, the dog affords 
researchers the opportunity to study naturally occurring models of human diseases. 
Importantly, large litter sizes and a short gestational period make the dog more amenable 
to genetic study than the human. Furthermore, our canine companions share our 
environment and also have a level of medical surveillance second only to the human 
(Ostrander et al. 2000). 
Evolutionarily and physiologically, the dog is more closely related to the human 
than is the mouse. Analyses using a 1.5X coverage of the canine genome sequence 
revealed that nearly two times as much human sequence could be aligned with the dog 
than with 8X sequence from the mouse (Kirkness et al. 2003). This sequence, assembled 
from a Standard Poodle by Celara, represents the first large scale sequencing effort for 
the dog. The potential of the canine sequence to contribute to understanding genetics of 
hereditary disease and comparative genetics was recognized by the National Human 
Genome Research Institute (NHGRI) (http://www/genome.gov/11008069). That is, the 
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dog was selected over other species for genome sequencing. After several breeds were 
analyzed for high levels of genetic homogeneity, the Boxer was chosen to be the breed 
sequenced. In 2003, assembly of a 6.5X coverage sequence of the dog commenced. Data 
are publicly available through the daily deposition of trace sequences into Ensembl 
(ftp://ftp.ensembl.org/pub/traces/canis_familiaris/) and NCBI Trace Archive 
(http://www.ncbi.nlm.nih.gov/Traces/trace). 
 
History of the canine map 
Today, construction of the ultimate map of the canine genome is nearly 
complete, but less than a decade ago researchers were struggling with standardizing the 
canine karyotype. This task was complicated by the dog’s 38 small, acrocentric 
autosomes that could not be readily distinguished by standard cytogenetic techniques. It 
was not until 1999, with the development of chromosome-specific fluorescence in situ 
hybridization (FISH) paint probes, that the canine karyotype was standardized (Breen et 
al. 1999a; Breen et al. 1999b). This development was an important step towards the 
construction of a high-resolution map of the canine genome, an essential tool for genetic 
studies in the dog.    
In 1997, Mellersh and colleagues published the first linkage map of the dog, 
which included 139 microsatellite markers and 30 linkage groups. Another milestone in 
development of the canine map was the construction of a radiation hybrid (RH) panel, 
using canine-rodent hybrid cell lines (Vignaux et al. 1999). The first RH map consisted 
of 218 gene markers and 182 microsatellite markers (Vignaux et al. 1999). More 
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recently, there was construction of an integrated linkage-radiation hybrid map of the 
canine genome (Breen et al. 2001).  
The integrated map allowed for identification of microsatellite markers suitable 
for whole genome linkage scans. Successful linkage studies require a set of markers that 
is distributed evenly across all chromosomes. The Minimal Screening Set–1 (MSS-1) is 
the first screening set providing full coverage of the canine genome (Richman et al. 
2001). It is comprised of 172 microsatellite markers, 64 di-, 3 tri-, and 104 tetra-
nucleotide markers, with an average polymorphic information content (PIC) value of 
0.74 (Richman et al. 2001). Average spacing for the MSS-1 is 10cM and no gaps greater 
than 20 cM exist (Richman et al. 2001). 
In 2003, an updated RH panel, RHDF5000-2, was used to map 3,270 markers 
with an average intermarker distance corresponding to ~1 Mb (Guyon et al. 2003). This 
facilitated the characterization of a more comprehensive screening set, the Minimal 
Screening Set -2 (MSS-2) (Guyon et al. 2003). The MSS-2, comprised of 327 
microsatellite markers, offers an average spacing of 9 Mb and has no gaps larger than 
17.1 Mb (Guyon et al. 2003). The MSS-2 includes 151 di-, 3 tri-, and 171 tetra-
nucleotide repeats with an average heterozygosity value of 0.73 (Guyon et al. 2003). 
Only 64 markers from the MSS-1 are part of the MSS-2 (Guyon et al. 2003). 
 
Linkage analysis in the dog 
Though the unique population structure of the dog lends itself to the study of 
human hereditary diseases, it is important to note that there are many diseases unique to 
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the dog. Because of the many roles of the dog in society, from guardian to companion, 
elimination of hereditary diseases is desirable. Approximately two-thirds of hereditary 
diseases in the dog are transmitted in an autosomal recessive fashion (Ostrander and 
Kruglyak 2000), which makes it difficult for breeders to eliminate deleterious alleles 
from the breeding stock. In addition, many hereditary diseases have late onset and are 
therefore difficult to prevent because dogs reach reproductive maturity before symptoms 
arise. Thus, identification of markers linked with diseases allows for the development of 
PCR-based tests that can identify carrier and affected animals before symptoms occur.   
There exist two basic strategies to identify genes harboring mutations that are 
causative for diseases. The candidate gene approach is a more direct method and focuses 
on specific genes that are suspected to be involved in the diseases. For some diseases, 
many candidate genes have been identified, however, for others, the limited knowledge 
of the pathobiology of the underlying disease process prevents the selection of suitable 
candidate genes. In these situations, recombination mapping strategies, such as classical 
linkage analysis and linkage disequilibrium (LD), may be employed. After linkage has 
been established, identification and subsequent positional cloning of candidate genes is 
possible.  
Classical linkage studies use known relationships to trace inheritance through a 
family. Although it is necessary to construct multigenerational pedigrees for these 
studies, collaborations with breeders can obviate the need to maintain expensive 
colonies. An alternative to classical linkage studies is LD, which uses small numbers of 
unrelated affected and unaffected dogs. Purebred dogs are well suited for LD, which 
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requires a young population with certain structures, including genetic isolation, a small 
number of founders, expansion by growth, and rare disease alleles (Hyun et al. 2003).  
 
Multiplexing 
The recent characterization of highly polymorphic microsatellite markers is an 
important advance in the study of canine genomics. Microsatellites are useful as markers 
for linkage analysis, as well as for evolutionary studies and forensics investigations 
(Leopoldino et al. 2002). Variability of microsatellites within and among breeds allows 
for their use in identification of individuals and determination of parentage (Sutton et al. 
1998; Zajc and Sampson 1999; Muller et al. 1999; Clark et al. 2004). High sequence 
conservation within the family Canidae allows for comparative studies of microsatellites 
across canine species (Fredholm and Winterø 1995). The generation of microsatellite 
profiles for individuals is termed genotyping.  
A limiting factor in the use of microsatellites is the availability of DNA from 
subjects of interest. Thus, it is desirable to minimize the number of PCRs necessary to 
collect genotypes because the amount of DNA is often limited and because materials, 
reagents, and resolution of PCR products are costly. One mechanism to address this 
issue is the multiplexing of markers. Multiplexing is the simultaneous amplification and 
resolution of PCR products. Multiplex PCR has been developed for linkage studies in 
the human (Beekman et al. 2001), and for forensics investigations in several mammals, 
including the dog (Koskinen and Bredbacka 1999, Altet et al. 2001, Clark et al. 2004). In 
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short, multiplexed sets of markers reduce both the expense and time necessary for 
collection of genotype data. 
 
Pancreatic acinar atrophy 
Pancreatic acinar atrophy (PAA) is a disease characterized by the degeneration of 
acinar cells of the exocrine pancreas that leads to exocrine pancreatic insufficiency (EPI) 
and occurs primarily in the German Shepherd Dog (GSD) (Westermarck et al. 1993). 
Pancreatic acinar cells synthesize digestive enzymes such as lipase and amylase, and 
also inactive precursors, zymogens, of proteolytic and phospholipolytic enzymes 
necessary for proper digestion (Williams 1989). The aforementioned enzymes and 
zymogens are secreted into the small intestine and are instrumental in the breakdown of 
fats, carbohydrates, and proteins (Williams 1989). The pancreas also functions as an 
endocrine gland, wherein the islets of Langerhans secrete the hormones insulin and 
glucagon, which regulate glucose homeostasis in the body. This function is not disrupted 
as a result of PAA (Archibald and Whiteford 1953).  
Ninety-six percent of affected dogs present with symptoms of EPI by five years 
of age, although many dogs show signs as early as 6 months of age (Raiha and 
Westermarck 1989; Westermarck et al. 1993). More than 90% of the secretory capacity 
of the pancreas has to be lost before clinical symptoms ensue (Dimagno et al. 1973). 
Clinical signs include a ravenous appetite, weight loss, and voluminous soft stools 
(Westermarck et al. 1989). Steatorrhea, borborygmus, coprophagia, and polydipsia are 
also associated with EPI (Raiha and Westermarck 1989).  
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Histological studies 
PAA is unique to the dog (Westermarck and Wiberg 2003). Histologic evaluation 
of pancreatic biopsy specimens from dogs having PAA reveals atrophy, scattering, and 
disorganization of pancreatic acinar cells (Rogers et al. 1983; Westermarck et al. 1993). 
Abnormal acinar cells can be identified as early as 6 weeks of age (Westermarck et al. 
1993). Degenerating acinar cells exhibit dilation of the rough endoplasmic reticulum 
(RER) and extensive fusion of zymogen granules (Westermarck et al. 1993). These 
changes progressively affect larger portions of acinar tissue, and ultimately result in a 
severely diminished exocrine pancreatic function (Westermarck et al. 1993).  
One group recently examined the histopathology of pancreatic tissue during the 
subclinical phase, that is, before the complete destruction of the exocrine pancreas 
(Wiberg et al. 1999). They observed a marked infiltration of the exocrine pancreas with 
lymphocytes (Wiberg et al. 1999). During the clinical stage, only a mild inflammatory 
reaction is observed. Thus, these investigators proposed that PAA progresses through 
two stages: 1) lymphocytic pancreatitis, during which there is active destruction of 
acinar tissue, and 2) end-stage EPI, during which atypical parenchyma, ductal structures, 
and adipose tissue replace acinar tissue (Wiberg et al. 1999).  
 
Diagnosis and treatment 
Previously, the fecal soybean stimulation test (SST), fecal proteolytic activity 
(FPA), and N-benzoyl-L-tyrosyl-P-aminobenzoic acid absorption test (BT-PABA) have 
been used for the diagnosis of EPI (Westermarck 1982; Westermarck et al. 1993). 
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However, these tests are either cumbersome to perform and/or are unreliable (Williams 
and Batt 1988). Today the measurement of serum canine trypsin-like immunoreactivity 
(cTLI) using a radioimmunoassay, which determines the amount of trypsinogen released 
into the bloodstream from the pancreas, serves as a gold standard (Williams and Batt 
1988). The reference range for this assay is 5.0 µg/L to 35.0 µg/L, and values below 2.5 
µg/L are diagnostic for EPI (Williams et al. 1988). This assay has been reported to be 
100% sensitive and specific for EPI and thus is a clinically effective diagnostic tool 
(Williams and Batt 1988). 
 The prognosis for dogs having EPI is typically good with treatment (Wiberg et 
al. 1998). Expensive enzyme supplements must be administered with each meal for the 
duration of the animal’s life (Williams 1989). However, one fifth of dogs having EPI are 
euthanized because owners are unable to afford the enzyme supplements (Hall et al. 
1991). 
 
Heritability studies 
Many studies have been conducted in an effort to understand the mode of 
inheritance of PAA. Weber and Freudiger (1977) studied a multigenerational pedigree of 
GSDs and hypothesized that chronic exocrine pancreatic insufficiency is an autosomal 
recessive trait. Westermarck (1980) investigated the inheritance of PAA in a Finnish 
family of GSDs and also reported that it may have an autosomal recessive mode of 
inheritance. The above investigations, however, are problematic because statistical 
analyses necessary to conclusively determine a mode of inheritance were not conducted. 
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Specific objectives 
There were two major objectives of this work. The first was to develop tools for 
genomic analysis in the study of hereditary diseases of the domestic dog. This objective 
was achieved through the development of 1) multiplexing strategies for the MSS-1, 2) a 
multiplex of microsatellite markers for use in canine forensics (e.g., parentage 
identification of individual dogs, etc.), and 3) chromosome-specific multiplex panels for 
the MSS-2. The second objective of this work was to use these tools to study the 
genetics of EPI in the GSD. To accomplish this objective, it was necessary to 1) 
determine the mode of inheritance of PAA and 2) conduct a whole genome screen of 
pedigrees of GSDs segregating PAA. These two objectives have been met but linkage of 
markers with PAA has not, to date, been met. 
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CHAPTER II 
INHERITANCE OF PANCREATIC ACINAR ATROPHY IN GERMAN 
SHEPHERD DOGS* 
 
Overview 
Our objective was to assess the heritability of PAA in the GSD in the US. Two 
multigenerational pedigrees of GSDs with family members with PAA were identified. 
The clinical history of each GSD enrolled in the study was recorded and serum samples 
for cTLI analysis were collected in 102 dogs. Dogs with a cTLI concentration ≤ 2.0 µg/L 
were diagnosed with EPI and were assumed to have PAA. Pedigree I consists of 59 dogs 
and pedigree II of 76 dogs. Serum cTLI concentrations were measured in 48 dogs from 
Pedigree I and 54 dogs from pedigree II. A total of 19 dogs (14.1%) were diagnosed 
with EPI, 9 in pedigree I (15.3%) and 10 in pedigree II (13.6%). Of the 19 dogs with 
EPI, 8 were male and 11 were female. Evaluation of data by complex segregation 
analysis were strongly suggestive of an autosomal recessive mode of inheritance for this 
disease in GSDs in the US. Currently, linkage analysis is being performed in order to 
identify a genetic marker that co-segregates with PAA. Ultimately, this work is expected 
to lead to the development of a PCR-based  assay for a genetic marker that co-segregates 
 
 
 
_____________________________ 
* Reprinted with permission from Moeller EM, Steiner JM, Clark LA, Murphy KE, Famula TR, Williams 
DA, Stankovics M, Vose A (2002) Inheritance of pancreatic acinar atrophy in German Shepherd Dogs. 
Am J Vet Res 63, 1429-1434 
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with PAA in the GSD. Such a test may help to decrease the incidence of this disease 
through directed breeding programs. 
 
Introduction 
PAA is a degenerative disease of the exocrine pancreas, mainly seen in GSD and 
Rough-coated Collies, that leads to EPI (Weber and Freudiger 1977; Rogers et al. 1983; 
Raiha and Westermarck 1989; Westermarck et al. 1989; Westermarck et al. 1993).  
Affected dogs typically have clinical signs of EPI by five years of age, but some dogs 
may have signs as early as 13 months of age (Raiha and Westermarck 1989; 
Westermarck et al. 1989; Westermarck et al. 1993). Clinical signs include polyphagia, 
weight loss, voluminous stools, and steatorrhea (Archibald and Whiteford 1953; 
Anderson and Low 1965; Anderson and Low 1965; Rogers et al. 1983; Westermarck et 
al. 1989). Feces are light in color, loose in texture, and can be quite malodorous 
(Archibald and Whiteford 1953; Anderson and Low 1965; Anderson and Low 1965;  
Rogers et al. 1983; Westermarck et al. 1989). 
Findings on histologic evaluation of pancreatic biopsy specimens from dogs with 
PAA include atrophy, scattering, and disorganization of pancreatic acinar cells (Rogers 
et al. 1983; Westermarck et al. 1993). Electron microscopy of pancreatic tissue reveals 
degenerative changes of acinar cells as early as 6 weeks of age (Westermarck et al. 
1993). Abnormalities include dilation of the rough endoplasmic reticulum (RER) and 
extensive fusion of zymogen granules (Westermarck et al. 1993). As the disease 
progresses, the tissue loss becomes more extensive and leads to a rapid loss of exocrine 
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pancreatic function (Westermarck et al. 1993). Islets of Langerhans are usually 
unaffected by the degenerative process (Archibald and Whiteford 1953). 
A number of tests have been developed to aid in the diagnosis of EPI. The fecal 
soybean stimulation test, fecal proteolytic activity, and N-benzoyl-L-tyrosyl-P-
aminobenzoic acid absorption have all been used for the diagnosis of EPI (Westermarck 
1982; Westermarck et al. 1993). Unfortunately, all of these tests are either cumbersome 
to perform, unreliable, or both and have been replaced by the measurement of serum 
cTLI by use of a radioimmunoassay (Williams and Batt 1988). The reference range for 
this assay is 5.0 to 35.0 µg/L, with a value of < 2.5 µg/L being diagnostic of EPI 
(Williams and Batt 1988). Serum cTLI concentration has been reported to be 100% 
sensitive and specific for EPI and, thus, is clinically highly useful for the diagnosis of 
EPI (Williams and Batt 1988). In fact, the high sensitivity and specificity of serum cTLI 
concentration for a diagnosis of EPI make this disease an ideal candidate for evaluation 
as a hereditary disease. By using this assay, the disease status of any family member can 
be assessed easily. Recently, an assay for measurement of fecal elastase has been 
introduced (Spillmann 1998). However, this assay is associated with some false positive 
results, making it inferior to the measurement of serum cTLI concentration.  
In 1977, Weber and Freudiger analyzed a pedigree composed of 19 GSDs with 
EPI and 33 unaffected GSDs. All 19 affected dogs were found to have a common 
ancestor born in 1918. Eighteen of the dogs were inbred more than once with a 
descendant of this dog. On the basis of the degree of inbreeding within this pedigree, 
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Weber and Freudiger hypothesized that chronic EPI was an autosomal recessive trait 
(Weber and Freudiger 1977).  
In 1980, Westermarck et al investigated the inheritance of PAA in GSDs in 
Finland (Westermarck 1980). Measurement of fecal proteolytic activity was performed 
by use of radial enzyme diffusion to determine the disease status of each dog 
(Westermarck 1980). This study included 59 GSDs from 2 different kindreds that had 
the same male progenitor. The first kindred had at least 1 affected dog in each of 4 
litters. This evidence further supported an autosomal recessive inheritance of PAA in 
GSDs. However, Westermarck pointed out that on the basis of his data, the mode of 
inheritance could also be dominant with incomplete penetrance (Westermarck 1980). 
Recent work indicates that PAA might be an autoimmune-mediated disease. 
More specifically, it is theorized that PAA progresses through the following 2 stages: 1) 
lymphocytic pancreatitis, when there is active destruction of acinar tissue and 2) end-
stage EPI, during which atypical parenchyma, ductal structures, and adipose tissue 
replace acinar tissue (Wiberg et al. 1999). Thus, PAA in GSDs may represent an 
autoimmune disorder that is caused by a gene inherited in an autosomal recessive 
fashion.  Because previous studies have been conducted outside the United States, the 
purpose of the study presented here was to determine the inheritance of PAA in GSDs in 
the US.  
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Materials and methods 
A questionnaire was sent to veterinarians who had GSD patients with low serum 
cTLI concentrations as determined by previous analysis of serum samples at the 
Gastrointestinal Laboratory at Texas A&M University. Veterinarians were asked for 
permission to contact the owners of the dogs. Owners were then asked to provide 
information about the breeders they obtained their dogs from. Finally, breeders were 
contacted for family information and for participation in our study. Several families of 
GSDs having family members with EPI were identified, and 2 pedigrees were selected 
because dogs belonging to several generations were available. Many dogs related to 
these dogs previously determined to have EPI were identified, and as many dogs as 
possible were tested for EPI. No discrimination was made between dogs that had clinical 
signs of EPI and those that did not. Dogs previously determined to have EPI were 
retested when possible. 
A single serum sample was collected from each dog, stored in a 10 ml red-top 
red-top evacuated tube, and sent to the Gastrointestinal Laboratory for measurement of 
serum cTLI concentration by radioimmunoassay. The serum cTLI concentration was 
used to determine the disease status for each dog. Dogs with a serum cTLI concentration 
of ≤ 2.0 µg/L were considered to have EPI, and it was assumed that EPI was caused by 
PAA. For dogs that were retested (i.e., because they had no clinical signs of EPI but did 
have a low serum cTLI concentration previously), the most recent serum cTLI 
concentration was reported. Additional blood samples for future extraction of DNA were 
also collected and sent to the Gastrointestinal Laboratory. 
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Statistical analysis methods 
Logistic regression models developed for complex segregation analysis were 
used to assess the possible segregation of a single locus with a large effect on PAA in 
our pedigrees (Bonney 1986). For a review of complex segregation analysis, see Lynch 
and Walsh (Lynch and Walsh 1998). This technique, which contrasts possible modes of 
inheritance, is purely statistical, using pedigree information, disease status, and sex to 
identify a pattern of transmission. The data are fit to various models of transmission, and 
a likelihood ratio is calculated for each of these models. The likelihood ratio is a 
measurement of how well the data fit the model, and a P value is calculated to determine 
a significant difference between likelihood ratios. The data were fit to the different 
models by use of Statistical Analysis for Genetic Epidemiology (S.A.G.E.) software 
(Release 3.1). All dogs belonging to either of the pedigrees were used in the complex 
segregation analysis. Dogs with a serum cTLI concentration ≤ 2.0 µg/L were considered 
affected and all other dogs were considered unaffected. A value of P ≤ 0.05 was 
considered significant. 
  
Results 
A total of 135 togs were evaluated in our study. Serum cTLI concentration was 
measured in 102 of the 135 (75.6%) dogs. Nineteen of these 135 dogs (14.1% or 18.6% 
of the 102 dogs tested) had EPI, 8 of which were male and 11 female. The first family of 
GSDs consisted of 59 dogs, 48 of which had serum cTLI concentrations measured 
(Figure 1). Nine of those 59 (15.3%; 18.8% of the 48 dogs tested) dogs, including 4 
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males and 5 females, had serum cTLI concentrations ≤ 2.0 µg/L. Two dogs had serum 
cTLI concentrations of ≤ 2.0 µg/L but were asymptomatic for EPI. The second family of 
GSDs consisted of 76 dogs, 54 of which had serum cTLI concentrations measured 
(Figure 2). Ten of the 76 (13.2%; 18.5% of the 54 dogs that were tested) dogs, including 
4 males and 6 females, had serum cTLI concentrations of ≤ 2.0 µg/L. Thirty-three of the 
dogs were not tested for various reasons, including death at birth, death before clinical 
signs warranted testing, and lack of cooperation by the owner for sample collection. 
 
 
 
Figure 1. Pedigree I.  
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Figure 2. Pedigree II. 
 
 
Several litters from parents, of which at least 1 parent was affected, had 
unaffected individuals. Conversely, there were several litters with affected individuals 
from unaffected parents. Pedigree I represents data from 7 complete litters, whereas 
pedigree II represents data from 10 complete litters (Table 1). There were 2 dogs that did 
not have a diagnosis of EPI prior to being tested for the purpose of our study. Because 
both of these dogs had no clinical signs of EPI, these dogs were classified as having 
subclinical disease. One dog was retested for confirmation and also had a severely low 
serum cTLI concentration (cTLI ≤ 2.0 µg/L) at the time of the second evaluation. The 
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other dog died before a second sample could be collected. The serum cTLI concentration 
for this dog was 1.4 µg/L, suggesting that this dog was affected. 
When using a complex segregation analysis, dogs can either have the phenotype 
or not have the phenotype in question. Therefore, a cut-off point had to be established to 
distinguish affected dogs from unaffected dogs. The cut-off value chosen for our study 
was a serum cTLI concentration of ≤ 2.0 µg/L. Any dog with a serum cTLI 
concentration of ≤ 2.0 µg/L was considered affected, whereas all other dogs were 
considered unaffected. 
 
Table 1. Number of affected dogs with exocrine 
pancreatic insufficiency (EPI) in litters of 
German Shepherd Dogs from 2 pedigrees 
 # parents 
w/ EPI 
# affected 
in litter 
# dogs 
in litter 
0 0 5 
0 0 7 
0 1 4 
0 1 7 
1 0 6 
1 1 4 
Pedigree I 
1 5 10 
0 1 3 
0 1 4 
0 1 5 
0 1 5 
0 1 6 
0 1 6 
0 1 7 
0 1 8 
0 2 7 
Pedigree II 
1 0 7 
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Complex segregation analysis revealed that the most substantial contrast of 
likelihoods was between a model with no major locus, which included the possibility for 
polygenic inheritance, and a model with a single major locus exhibiting general 
Mendelian transmission. The model assuming general Mendelian transmission showed a 
significantly higher likelihood (p=0.046) than the model assuming no major locus (Table 
2). 
 
Table 2. Parameter estimates (± SE) from the logistic regression model in complex 
segregation analysis of pancreatic acinar atrophy (PAA) in German Shepherd Dogs 
 
 No Major Locus General Major 
Locus 
Arbitrary 
Transmission 
General Major 
Locus 
Mendelian 
Transmission 
Recessive Major 
Locus 
Mendelian 
Transmission 
Parameter Estimated SE Estimated SE Estimated SE Estimated SE 
p(a)a NAd  0.017 0.003 0.175 0.074 0.180 0.074 
Pooled Base -2.659 0.404 NA  NA  NA  
aa NA  2.938 2.028 1.033 0.711 1.274 2.416 
Aa NA  33.688 20.319 -68.112 15.647 -11.132 4.643 
AA NA  -11.998 10.921 -9.130 2.421 -11.132 4.643 
τaa NA  0.499 0.891 1.00 Fixed 1.00 Fixed 
τ Aa NA  0.298 0.524 0.50 Fixed 0.50 Fixed 
τ AA NA  0.001 0.000 0.00 Fixed 0.00 Fixed 
Parent Regr.c -0.124 0.249 -4.794 0.28 -3.976 0.832 -4.330 0.822 
         
ln(L)b -75.022  -70.381  -71.024  -71.915  
   A positive estimate value indicates an increased risk for PAA, whereas a negative estimate value 
indicates a reduced risk for PAA. The aa genotype, having a positive estimate, is likely to be affected. AA 
genotypes and heterozygotes, Aa, are least likely to develop PAA. 
   a Frequency of the putative major allele a. b Natural log of the likelihood. cRegression effect for parents.     
d  Estimate for each parameter calculated for the specific regression model   
   A = Dominant allele for PAA. a = Recessive allele for PAA. NA = Not applicable. τ = Major locus 
transmission probabilities for transmission of putative major allele a. 
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Discussion 
From a clinical standpoint, PAA in GSDs is a hereditary disease that can be 
readily diagnosed because identification of disease status can easily be accomplished by 
measuring a single serum cTLI concentration. The cTLI assay has been shown to be 
100% sensitive and 100% specific for diagnosing EPI in dogs (Williams and Batt 1988).  
The almost even distribution of PAA between males and females in the 2 pedigrees 
indicates that PAA is not a sex-linked disease. If PAA were inherited as an X-linked 
disease, we would expect many more males to be affected than females. Also, Y-linked 
inheritance would produce only affected males, which is not the case for PAA.   
Parents lacking clinical signs of EPI produced dogs with EPI. This provides 
further evidence that the putative trait for PAA is recessive and supports the findings in 
Finnish GSDs by Westermarck (Westermarck et al. 1989; Westermarck 1980). However, 
the rate of affected dogs is slightly lower than would be expected for a simple autosomal 
recessive inheritance (ie, 18/102 dogs belonging to complete litters; 17.8% compared to 
25.0% expected for simple autosomal recessive inheritance). This maybe explained by a 
higher rate of stillbirths in affected dogs or by the fact that at the time of analysis, some 
dogs had not yet reached 4 to 5 years of age. These dogs may develop clinical signs and 
a low serum cTLI concentration at a later time in life. Finally, we used a cut-off value of 
2.0 µg/L for serum cTLI concentration to ensure that all dogs with positive results truly 
were affected. In contrast, the cut-off value for serum cTLI concentration for EPI 
currently reported by our laboratory is ≤ 2.5 µg/L. This may have led to a small increase 
in false-negative results, decreasing the apparent prevalence of the disease.  
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Small intestinal disease is common in GSDs and may be associated with a slight 
decrease in serum cTLI concentrations. However, these low serum cTLI concentrations 
are > 2.5 µg/L. This clinical impression may account for dogs that had serum cTLI 
concentrations less than the lower limit of the reference range (5.0 µg/L) but still greater 
than the cut-off value for EPI (2.0 µg/L). For the purpose of our study, dogs with serum 
cTLI concentrations that fell into this range were considered not affected. 
At the time of our study, 17 dogs were not yet 4 years of age when they were 
tested for EPI. However, 7 of these dogs were siblings of dogs that had already been 
determined to have EPI. None of these dogs had any signs of EPI. Additionally, none of 
the remaining 10 dogs that were not yet 4 years of age and did not have siblings that had 
previously been determined to have EPI, had any clinical signs of EPI. Although some 
of these dogs may develop EPI in the future, we consider this possibility unlikely. These 
dogs were considered unaffected for the purpose of our study. 
Elston et al. outline criteria that must be satisfied before accepting a major gene 
model (Elston et al. 1975). The first model to fit is one with no major locus, which 
includes a term for polygenic inheritance. Alone, this model is uninformative, but it will 
serve as a baseline for future comparisons. The next model is one that includes a 
parameter for a major locus, an effect expected to pass from parent to offspring on the 
basis of Mendel’s laws. The contrast of these 2 models is insufficient to establish a 
putative major gene or to have a reduced incidence of false positives. Additional models 
fitted to the data include a major locus effect but estimate the transmission from parent 
to offspring.  
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In our study, the most substantial difference of likelihood ratios was seen 
between a model with no major locus, which included the possibility for polygenic 
inheritance and a model with a single major locus exhibiting general Mendelian 
transmission. The latter model resulted in a higher likelihood, indicating a better fit, and 
was shown to be significantly (P=0.046) different from the first model. A recessive 
Mendelian model was then compared with the original model of PAA having no major 
gene. It reported the maximal likelihood ratio and a significant (P=0.044) difference. 
These results support the theory that a major gene is responsible for PAA in these 
populations. 
Other models that were fitted to the data include a dominant Mendelian model 
and one with a term for sex differences. These models resulted in likelihood ratio 
statistics that were not significant (data not shown).  
Likelihood ratios for the different models are reported (Table 2), including the 
“general” major locus model (“general” meaning the locus does behave in a strict 
dominant or recessive manner). Mendelian transmission of the putative alleles provides a 
significantly better fit than a “no major locus model”.  For this comparison, the log of 
the likelihood ratio is calculated as follows: -2(-75.022– (-71.024)) = 7.996, with 3 
degrees of freedom (P < 0.046). However, a “general major locus model” where the 
transmission probabilities are estimated from the pattern of inheritance displayed within 
the data does not provide a significantly better fit than the “general model with fixed 
Mendelian transmission probabilities” (i.e., -2(-71.024 – (-70.381)) = 1.286, with 3 
degrees of freedom P < 0.732). This contrast between the two models is suggested by 
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Elston et al. to reduce the probability of falsely declaring the presence of a major locus 
(Elston et al. 1975). Alleles of a genuine major locus would have to be transmitted from 
parent to offspring with probabilities that reflect Mendelian transmission. A test for 
equal transmission probabilities (not presented) also supports the 3 criteria of a major 
locus model as described by Elston et al. The recessive major locus model was not 
significantly different from the general major locus model (-2(-71.915– (-71.024)) = 
1.782, with 1 degree of freedom, P < 0.182), though the recessive model is more 
parsimonious. Accordingly, we conclude that a major locus with an impact on PAA in 
GSDs in the United States can be established with the present data. This major locus 
apparently acts in a recessive, or close to completely recessive, fashion. 
Statistical analysis supports the theory that a major gene is responsible for PAA 
in the pedigrees evaluated in our study. The single major locus model exhibiting general 
Mendelian transmission had a higher likelihood than the model assuming no major 
locus. This indicates that the single major locus model has a better fit to the data 
observed in these pedigrees. In addition, the recessive Mendelian model had the 
maximal likelihood ratio and significant difference from the model assuming no major 
gene. Because no other Mendelian models had significant likelihood ratio statistics, 
these data suggest that the mode of inheritance of PAA in GSDs in the United States is 
autosomal recessive. 
One problem in our study is that for some litters, blood samples could not be 
collected from all the dogs. For instance, several dogs in pedigree II (Figure 2) were 
stillborn or died before the disease could have developed. There is no way to exclude the 
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possibility that some of these dogs would have developed PAA later in life. 
Additionally, other dogs died before follow-up samples could be collected. These losses 
may affect the observed incidence of PAA and may explain the lower than expected 
frequency observed in these 2 pedigrees. The only definitive way to determine whether a 
dog is affected with PAA would be to only include pedigrees that exclusively contain 
family members that live a full lifespan and in which a determination of disease status is 
being made shortly before a natural death. Unfortunately, such a study would not be 
feasible.  
We conclude that there is evidence to suggest that PAA is inherited as an 
autosomal recessive trait in GSDs in the United States. Currently, linkage analysis is 
being performed by use of a set of 172 microsatellite markers (ie. MSS-1) that spans the 
entire canine genome (Richman et al. 2001).  Since no candidate gene is available for 
PAA, the minimal screening set 1 is screened for a microsatellite marker that 
cosegregates with the disease.  
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CHAPTER III 
MULTIPLEXING OF CANINE MICROSATELLITE MARKERS FOR WHOLE 
GENOME SCREENS* 
 
Overview 
A set of 172 canine microsatellite markers, termed Minimal Screening Set-1 
(MSS-1), was recently characterized for use in whole-genome screens. We report here 
the multiplexing of 155 MSS-1 markers into 48 multiplex sets. Amplification of the 
multiplex sets is achieved using a single thermal cycling program. The markers are 
labeled with fluorescent dyes and optimized for resolution on an ABI 310 Genetic 
Analyzer or ABI 377 Sequencer. The multiplexing strategy involves amplifying 
combinations of markers so that no two markers with the same dye and product size 
overlap. Multiplexing the MSS-1 provides an efficient tool for the collection of 
genotypes and streamlines whole genome screens. Screening the canine genome for 
linkage of markers with various hereditary diseases facilitates identification of affected 
and carrier individuals, thereby providing researchers and clinicians with an additional 
diagnostic tool. 
 
 
 
 
______________________________ 
∗ Reprinted with permission from Cargill EJ, Clark LA, Steiner JM, Murphy KE (2002) Multiplexing of 
canine microsatellite markers for whole-genome screens. Genomics 80(3), 250-253 
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Introduction 
More than 400 hereditary diseases of the domestic dog have been described, and 
more than 200 of these have pathologies resembling specific human hereditary diseases 
(Ostrander et al. 2000). Furthermore, many canine and human hereditary diseases have 
common genetic etiologies. This fact, combined with the marked genetic homogeneity 
and the ease with which multigenerational pedigrees can be established, makes the dog 
an ideal model for the study of simple and complex human hereditary diseases. Even so, 
until very recently an impediment to the study of canine hereditary diseases and to the 
use of the dog as a model has been the lack of a high-density map of the canine genome. 
However, advancements towards development of such a resource have come from 
construction of radiation hybrid (RH) (Priat et al. 1998) and linkage maps (Werner et al. 
1999). The subsequent integration of these maps provides coverage of approximately 
99% of the canine genome (Mellersh et al. 2000).  The most recent advance is an 1800-
marker map replete with microsatellite and gene loci (Breen et al. 2001). This rapid 
development of the canine map allows for tools that are readily available for study of the 
human (Lapsys et al. 1997; Li et al. 2001; Beekman et al. 2001), murine (Rithidech et al. 
1997; Devereux and Kaplan 1998) and bovine genomes (Womack et al. 1997; Konfortov 
et al. 1998; Grosse et al. 2000) to now be used in examination of the canine. 
The MSS-1 is suitable for genome-wide linkage studies because it provides 
coverage of the canine genome with average spacing of 10 cM and an average 
polymorphic information content (PIC) value of 0.74 (Richman et al. 2001).  The MSS-1 
contains 64 dinucleotide repeats, three trinucleotide repeats, 104 tetranucleotide repeats 
  
28
and one short interspersed nuclear element. Although the MSS-1 is an extremely useful 
tool, multiplexing will enhance its utility by allowing for more efficient genotyping. 
Multiplexing has already been utilized for linkage studies and verification of lineage in 
bison (Schanbel et al. 2000), cattle (Schanbel et al. 2000), humans (Beekman et al. 
2001), and dogs (Koskinen and Bredbacka 1999; Altet et al. 2001). To this end, we 
report here the multiplexing of 155 MSS-1 markers into 48 sets of two to five markers 
with 151 co-amplified and four co-loaded. The remaining 17 MSS1 markers were 
amplified and resolved individually.  
 
Materials and methods 
DNA from a mixed breed dog was used for optimization of the multiplex sets. 
Genomic DNA was extracted from whole blood using the Puregene DNA Isolation Kit 
(Gentra Systems, Minneapolis, MN). DNA was stored at 4oC in 150 µl of rehydration 
buffer. The concentration of the DNA was determined by spectrophotometric analysis 
and a working solution of 50 ng/µl was maintained. 
The microsatellite primers were synthesized using an ABI Expedite Nucleic Acid 
Synthesis System (PE Biosystems, Foster City, CA). The 5´-end of each forward primer 
was labeled with one of three fluorescent dyes:  6-FAM, HEX, or TET (PE Biosystems). 
Dyes were selected based on product size ranges (Richman et al. 2001) to evenly 
distribute dye type and to limit marker overlap. 
The multiplex sets and individual markers were amplifiabled with stepdown 
thermal cycling conditions of 2 min 95oC followed by 5 cycles of 30 seconds at 95oC, 15 
  
29
seconds at 58oC, 10 seconds at 72oC, and an additional 30 cycles of 20 seconds at 95oC, 
15 seconds at 56oC, 10 seconds at 72oC, with a final extension of 5 minutes at 72oC. 
Concentrations for a 10 µl PCR volume were 0.5 mM of each dNTP, 5 ng/µl of genomic 
DNA, 3.0 mM of MgCl, 1x Taq DNA Polymerase Buffer B (Fisher Scientific, 
Pittsburgh, PA), 1x MasterAmp PCR Enhancer (Epicentre Technologies, Madison, WI), 
and 0.04 units/µl of Taq DNA Polymerase (Fisher Scientific, Pittsburgh, PA).  Primer 
concentrations were varied for each marker (Table 4). Amplifications were carried out 
using an Eppendorf Mastercycler (Eppendorf Scientific, Inc., New York, NY). To co-
load markers in multiplex sets M47 and M48, individual markers were amplified and 
equal parts of reaction products were mixed together. 
Products of reactions were resolved using an ABI 310 capillary-based Genetic 
Analyzer or an ABI 377 Sequencer (PE Biosystems) and sized relative to an internal size 
standard (MAPMARKER HI, Bioventures). The ABI GENESCAN version 3.1 software 
package (PE Biosystems) was used for analysis of the multiplex sets. 
 
Results 
The MSS-1 markers have individual amplification conditions and observed 
product sizes (Richman et al. 2001). A complete list of references for each marker can be 
found on-line (http://www.cvm.tamu.edu/cgr/multiplex.html). For multiplexing, 53 
markers were labeled with 6FAM, 53 markers were labeled with HEX, and 66 markers 
were labeled with TET. In an effort to further enhance multiplexing, one PCR mix and 
one thermal cycling program were developed for amplification of the markers. To 
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determine compatibility for multiplexing, markers were amplified in various 
combinations.  Multiplex set optimization was completed by variation of primer 
concentrations to give approximately equal amplification of each product in a set.   
The use of three fluorescent dyes permits overlap of similarly sized markers, and 
48 multiplex sets of two to five markers were developed. More specifically, 151 markers 
can be co-amplified and 4 markers can be co-loaded after individual amplification. This 
reduces the number of reactions required to generate data for the MSS-1 by 60%, from 
172 to 69. Table 3 lists each multiplex set as they correspond to each canine linkage 
group. The multiplex sets, primer concentrations, and fluorescent dyes are listed in Table 
4. 
A table sorted by canine linkage group listing the MSS-1 markers, primer 
sequences, PIC values, heterozygosity values, marker types, fluorescent dyes, observed 
allelic sizes, primer concentrations, multiplex sets, and marker references is available 
(http://www.cvm.tamu.edu/cgr/multiplex.html). Of the 172 markers, 155 are multiplexed 
and the remaining 17 are amplified individually because they are not compatible in any 
multiplex combinations. Of these 17, 8 amplify under the same conditions as the 
multiplex sets (C10.16, FH2200, FH2347, RVCE, FH2165, REN06C11, FH2538, 
CXX.390.2), whereas 9 do not amplify under the multiplex conditions (ZuBeCa6, 
FH2149, FH2279, FH2346, N41, FH2457, AHT006, REN51i12, FH2600). The 
multiplexed MSS-1 provides an expedient and cost-effective method for collection of 
genotype information by reducing the number of reactions, quantities of reagents, and 
time required for whole-genome screens of the dog. 
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Table 3.  Multiplex sets as they correspond to each canine linkage group. 
 
Linkage  
Group Multiplex Sets 
Linkage  
Group Multiplex Sets 
CFA1 M02 M08 M13 M17 CFY M32 
CFA2 M17 M21 M22 M23 M28 M46 S1/L2 M01 M22 M25 M28 M45 
CFA3 M11 M12 M26 M38 M42 M48 S2/L13 M09 M37 
CFA5 M14 M25 M27 M43 S3/L14 M09 M15 M44 
CFA6 M13 M20 M38 M47 S4/L3 M01 M07 M13 M19 M29 M42 M43 
CFA7/L1 M03 M11 M12 M27 M45 S5/L18 M07 M29 M44 
CFA8 M03 M08 M21 M27 S6/L12 M24 M32 M39 M44 
CFA9 M01 M08 M35 S7/L7 M08 M39 M41 
CFA10 M18 M33 M37 S8/L8 M15 M41 M46 
CFA12/L4 M32 M38 S9/L5 M08 M28 M40 
CFA13,19/L17 M16 M35 S10/L6 M23 M31 M40 M42 
CFA15 M14 M20 M21 S11/L9 M14 M29 M34 M36 
CFA16 M01 M05 M18 S12/L11 M31 M37 M47 
CFA18 M05 M12 M23 M26 S13/L10 M24 M33, M45 
CFA20 M01 M40 M41 M43 M48 S14/L15 M30 M32 M35 
CFA22 M14 M22 M30 M31 M48 S15/L20 M16 M25 M34 M36 
CFA26 M02 M06 M15 M39 S16/L21 M33 M39 
CFA29,35/L16 M06 S17/L22 M19 M34 
CFA30/L19 M04 M06 M24 M26 L1/L23 M19 
CFX M04 M07 Unlinked M10 M16 M20 M30 M36 M47 
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Table 4.  Multiplex sets (M01 through M48) with marker primer concentrations a and 
fluorescent dyes b. 
Multiplex Conc.  Dye Multiplex Conc.  Dye Multiplex Conc.  Dye Multiplex Conc.  Dye 
M01        
FH2263      
FH2289 
CPH16 
AHT103 
AHT137 
 
0.8     T 
0.8     T 
0.8     F 
0.8     F 
0.8     T 
M13 
C01.673 
C06.636 
LEI001 
 
 
1.0     H 
1.0     T 
0.6     F 
 
M25 
CPH18 
FH2594 
FH2142 
CPH2 
 
0.8     F 
0.8     F 
0.8     H 
0.8     T 
M37 
FH2339 
FH2312 
FH2155 
 
 
1.0     F 
1.0     H 
1.0     H 
 
M02 
C01.246 
C01.424 
FH2016 
REN01O23 
C26.733 
 
0.8     F 
0.8     F 
0.8     T 
0.8     H 
0.8     F 
M14 
C05.377 
CPH5 
FH2283 
AHT133 
 
1.0     H 
0.8     F 
0.8     F 
0.6     T 
M26 
FH2531 
FH2429 
FH2305 
 
0.8     F 
0.8     H 
0.4     T 
M38 
FH2107 
FH2525 
FH2223 
 
0.8     H 
0.8     T 
0.8     F 
M03 
FH2201 
FH2174 
C08.618 
 
1.0     T 
0.8     H 
0.8     F 
M15 
FH2130 
FH2385 
CXX.391 
 
1.0     H 
1.2     T 
0.6     H 
M27 
GLUT4 
C07.1000 
FH2138 
 
0.8     T 
0.8     F 
0.8     T 
M39 
FH2171 
REN49F22 
CPH10 
FH2566 
 
1.0     H 
0.8    H 
1.2     T 
0.8     F 
M04 
1F11 
F8C 
FH2584 
 
0.8     T 
1.0     T 
1.0     H 
M16 
AHT124 
AHT127 
PEZ2 
AHT106 
 
0.4     F 
0.8     T 
2.0     H 
0.4     T 
M28 
FH2062 
AHT128 
FH2547 
 
0.8     H 
0.8     F 
0.6     T 
M40 
AHTk209 
PEZ10 
CXX.213 
 
0.8     H 
0.8     T 
0.8     T 
M05 
LEI002 
FH2356 
FH3010 
 
0.8     F 
1.0     T 
1.0     T 
M17 
FH2598 
FH2309 
AHT132 
 
1.0     H 
1.0     H 
0.8     F 
M29 
CXX.750 
FH2159 
FH2587 
 
0.8     T 
0.8     H 
0.8     T 
M41 
PRKCD 
REN49C08 
CXX.900 
 
1.0     H 
1.4     F 
1.0     T 
M06 
REN48E01 
FH2507 
FH2050 
 
1.0     H 
0.6     T 
0.6     F 
M18 
FH2422 
FH2293 
PEZ6 
 
0.8     T 
0.8     T 
0.8     F 
M30 
C22.745 
CXX.176 
CXX.452 
 
0.8     T 
0.8     T 
0.8     F 
M42 
C03.895 
FH2018 
AHT140 
 
0.6     T 
0.4     H 
0.6     F 
M07 
FH2548 
FH2985 
FH2096 
FH2079 
 
0.8     H 
0.8     H 
0.8     F 
0.8     T 
M19 
CXX.873 
REN02C20 
CXX.672 
FH2516 
 
0.8     T 
0.8     F 
0.8     F 
0.8     T 
M31 
FH2325 
FH2141 
FH2175 
 
0.8     T 
0.8     H 
0.8     F 
M43 
FH2383 
FH2528 
FH2319 
 
1.0     F 
0.4     T 
0.8     H 
M08 
FH2294 
C08.410 
GALK1 
CXX.279 
FH2060 
 
0.8     H 
0.8     F 
0.8     T 
0.8     T 
0.8     F 
M20 
CPH3 
FH2321 
TAT 
 
1.2     T 
0.8     T 
0.8     F 
M32 
C12.852 
AHT139 
FH2585 
SRY 
 
0.8     T 
0.8     T 
0.8     F 
0.8     H 
M44 
FH2364 
FH2261 
FH2278 
 
1.4     F 
0.8     F 
1.0     H 
M09 
FH2441 
FH2233 
REN45F03 
 
0.8     H 
1.0     F 
0.8     F 
M21 
C02.342 
FH2144 
Cos15 
 
0.6     F 
1.0     H 
1.0     T 
M33 
FH2537 
FH2199 
PEZ8 
 
0.8     H 
0.8     F 
0.8     H 
M45 
FH2396 
FH2534 
FH2239 
 
1.0     F 
0.6     T 
0.6     H 
M10 
FH2247 
REN01G01 
FH2377 
 
0.8     F 
0.8     T 
0.8     T 
M22 
FH2132 
FH2001 
FH2412 
 
1.0     T 
0.8     F 
0.8     H 
M34 
CXX.172 
REN41D20 
FH2244 
 
0.4     T 
0.8     F 
0.6     T 
M46 
C02.864.A 
FH2394 
 
0.8     T 
0.8     T 
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Table 4.  Continued. 
Multiplex Conc.  Dye Multiplex Conc.  Dye Multiplex Conc.  Dye Multiplex Conc.  Dye 
M11 
FH2137 
FH2301 
FH2581 
 
0.8     T 
0.8     F 
0.8     T 
M23 
FH2087U 
WILMS-TF 
FH2526 
 
0.8     H 
0.8     H 
0.8     T 
M35 
FH2186 
FH2206 
FH2208 
 
1.0     T 
1.0     T 
0.8     H 
M47 c 
FH2119 
AHT131 
PEZ7 a 
 
0.8     H 
0.8     T 
0.8     F 
M12 
FH2302 
FH2226 
AHT130 
 
0.8     T 
0.8     H 
0.8     F 
M24 
FH2290 
CXX.608 
CXX.642 
 
0.8     H 
0.8     H 
0.6     T 
M36 
FH2532 
FH2238 
FH2550 
 
0.8     H 
0.6     T 
0.8     F 
M48 d 
FH2316 
REN55P21 
FH2227 
 
0.8     H 
0.8     H 
0.8     H 
a Primer concentration in final reaction as µmol/primer, see http://www.cvm.tamu.edu/cgr/multiplex.html 
b F = 6-FAM, H = HEX, T = TET. 
c M47 co-amplify FH2119 and AHT131, individually amplify PEZ7, mix products 1:1 for co-loading. 
d M48 individually amplify FH2316, REN55P21, and FH2227, mix products 1:1 for co-loading. 
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CHAPTER IV 
EVALUATION OF A RAPID SINGLE MULTIPLEX MICROSATELLITE-
BASED ASSAY FOR USE IN FORENSIC GENETIC INVESTIGATIONS IN 
DOGS* 
 
Overview 
Our objective was to develop a set of microsatellite markers, composed of a 
minimal number of these markers, suitable for use in forensic genetic investigations in 
dogs. Blood, tissue, or buccal epithelial cells were collected from 364 dogs of 85 pure 
breeds and mixed breed dogs, and 19 animals from related species in the family 
Canidae. Sixty-one tetranucleotide microsatellite markers were characterized on the 
basis of number and size of alleles, ease of genotyping, chromosomal location, and 
ability to be co-amplified. The range in allele size, number of alleles, total 
heterozygosity, and fixation index for each marker were determined by use of genotype 
data from 383 dogs and related species. Polymorphism information content was 
calculated for several breeds of dogs. Seven microsatellite markers could be co-
amplified. These markers were labeled with fluorescent dyes, multiplexed into a single 
reaction, and optimized for resolution in a commercial genetic analyzer.  The utility of 
the multiplex  set was shown by identifying sires for two mixed litters.  This test was not 
 
 
 
_____________________________ 
* Reprinted with permission from Clark LA, Famula TR, Murphy KE (2004) Evaluation of a rapid single 
multiplex microsatellite-based assay for use in forensic-genetic investigations in dogs. Am J Vet Res, In 
Press. 
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species specific; genotype information collected for wolves, coyotes, jackals, New 
Guinea singing dogs, and an African wild dog could not distinguish between these 
relatives of the dog. This set of 7 microsatellite markers is useful for forensic 
applications (i.e., identification of dogs and determination of parentage) in closely 
related animals and is applicable to a wide range of species belonging to the family 
Canidae. 
 
Introduction 
 Microsatellite markers are tandem repeats of 1 to 6 bp that are abundant and 
evenly distributed across vertebrate genomes. Errors during DNA replication (slippage) 
occur when the polymerase loses its place and causes loss or gain of tandem repeats, 
resulting in microsatellites that are highly polymorphic. This polymorphic nature, in 
conjunction with their strict Mendelian inheritance and the ease with which genotypes 
can be collected, has made microsatellites the markers of choice for use in forensic 
genetic investigations (i.e., determination of parentage and identification of individuals) 
(Leopoldino et al. 2002).  
Studies of microsatellites in dogs reveal their variability within and among 
breeds as well as their utility in identifying individuals and determining parentage (Binns 
et al. 1995; Fredholm and Winterø 1996; Sutton et al. 1998; Zajc and Sampson 1998; 
Muller et al. 1999; Ichikawa et al. 2001). High sequence conservation within the family 
Canidae also allows comparative studies of canine microsatellites across species 
(Fredholm and Winterø 1995). 
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It is desirable to minimize the number of polymerase chain reactions (PCR) 
required to collect genotype information because the amount of available DNA is often 
limited; materials, reagents, and resolution of PCR products on a genetic analyzer are 
costly; and data can be generated more efficiently. Until recently, it has been difficult to 
assemble a panel of microsatellite markers suitable for use in canine forensic 
investigations because purebreed dogs have been highly inbred and line bred, resulting 
in decreased allelic diversity (Pihkanen et al. 1996). 
 In 2001, Richman et al. characterized a set of 172 microsatellite markers (MSS-
1) that was suitable for use in canine whole genome screens. All markers of the MSS-1 
were genotyped on panels of 17 reference families or radiation hybrid cell lines and were 
selected on the basis of high informativeness and inclusion in linkage groups (Mellersh 
et al. 1997; Neff et al. 1999; Vignaux et al. 1999; Richman et al. 2001). To enhance the 
utility of the MSS-1, our group multiplexed 155 markers into 48 multiplex sets (Cargill 
et al. 2002). Multiplexing is the simultaneous amplification and resolution of markers. 
Much of the debate regarding the use of DNA for forensic investigations has 
focused on issues of statistics and population genetics.  Part of the concern is about the 
accuracy and validity of the data collected and issues of population sampling. The focus 
of forensic genetics is the computation of a match probability, an expression that 
requires the knowledge of allelic frequencies and fixation index (FST), a measure of 
population diversity (Hartl and Clark 1997; Evett and Weir 1998). Implicit in the 
calculation of a match probability is the effect of population subdivision on the 
independence of alleles in the population as a whole. 
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Specifically, FST measures the amount of genetic variation in the entire 
population of dogs that can be attributed to differentiation among subpopulations (i.e., 
breeds), such that when FST = 0 there are no genetic differences among subpopulations. 
Algebraically, FST = (HT  HS)/HT, where HT is the measure of the total heterozygosity 
for a locus (i.e., the probability that 2 gametes chosen at random from the total 
population will carry different alleles) and HS is the subpopulation heterozygosity (i.e., 
the mean heterozygosity among subpopulations).  
Although PIC values are not involved in the calculation of match probabilities, 
many forensic geneticists use PIC values as a means of characterizing the diversity of 
allelic and genotypic frequencies for a given locus. This statistic is bound by 0.0 and 1.0 
such that the closer the value is to 1.0, the greater the amount of polymorphism, and 
therefore linkage information, captured by this locus (Botstein et al. 1980; Liu 1998). 
The purpose of the study reported here was to develop a set of microsatellite 
markers, composed of a minimal number of these markers, suitable for use in forensic 
genetic investigations in dogs and with advantages over multiplexed parentage tests 
already available (Koskinen and Bredbacka 1999; Altet et al. 2001). 
 
 
Materials and methods 
Selection of microsatellite markers 
Sixty-one tetranucleotide microsatellite markers with high (> 0.5 ) PIC values 
(measurements of variability at a locus) were selected from the MSS-1 for analysis. To 
characterize these microsatellite markers, preliminary data, including number of alleles 
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and peak morphology, were collected from multigenerational pedigrees of German 
Shepherd Dogs, a family of mixed breed dogs, and several groups of purebreed dogs. A 
subset of 11 microsatellite markers was selected on the basis of the number and range of 
allelic sizes, ease of genotyping, and chromosomal location.  Marker compatibility was 
determined via PCR amplification of various combinations of the 11 markers until co-
amplification of a maximum number of markers was obtained. 
 
Samples for genotyping 
Blood, tissue, or buccal epithelial cell samples collected from dogs and related 
species were donated by owners, collaborating laboratories, and breeders and exhibitors 
at dog shows. Relatives of dogs that were collected include the gray wolf (Canis lupus), 
Mexican wolf (Canis lupus baileyi), red wolf (Canis rufus), maned wolf (Chrysocyon 
brachyurus), coyote (Canis latrans), jackal (Canis adustus, Canis mesomelas, and Canis 
aureus), African wild dog (Lycaon pictus), and New Guinea singing dog (Canis 
hallstromi). Genotyping was also performed to determine the paternity of 2 potentially 
mixed litters. Genomic DNA was isolated from whole blood and buccal cells using the 
Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, MN) and from tissue using 
the DNeasy Tissue Kit (Qiagen, Valencia, CA). Working solutions of 50 ng of DNA/µL 
were prepared.  
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DNA amplification 
The 5′ end of the forward primer for each microsatellite marker selected was 
labeled with 1 of 4 fluorescent dyes (6-carboxy-fluorescein [6FAM], VIC®, NED®, or 
PET®)c (Table 5). Labels were chosen on the basis of observed allelic sizes to prevent 
overlap of dye types. Concentrations for a 13.45 µl PCR volume were 0.37 mM total 
dNTPs, 3.7 ng/µl genomic DNA, 2.2 mM of MgCl, 0.74X Taq DNA Polymerase Buffer 
B (Fisher Scientific, Pittsburgh, PA), 0.74× MasterAmp PCR Enhancer (Epicentre 
Technologies, Madison, WI), and 0.06 units/µl of Taq DNA polymerase (Fisher 
Scientific). Concentrations of primers varied for each microsatellite marker. Thermal 
cycling conditions for DNA amplification were 2 minutes at 95ûC; 5 cycles of 30 
seconds at 95ûC, 15 seconds at 58ûC, and 10 seconds at 72ûC; 30 cycles of 20 seconds at 
95ûC, 15 seconds at 56ûC, and 10 seconds at 72ûC; and a final extension of 5 minutes at 
72ûC using an Eppendorf Mastercycler (Eppendorf Scientific, Inc., New York, NY). 
 Products of reactions were resolved using an ABI 3100 capillary-based Genetic 
Analyzer (PE Biosystems, Foster City, CA) and were sized relative to an internal size 
standard (GeneScan 500 LIZ, PE Biosystems). Genotypes were assigned using 
Genotyper 2.0 (PE Biosystems). 
 
Calculation of HT, HS, FST, and PIC values 
 Calculations of HT, HS, and FST were performed by use of public domain 
software GENEPOP (Version 3.3) (http://wbiomed.curtin.edu.au/genepop/).  Total 
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heterozygosity and FST were calculated for each microsatellite marker by use of 
genotype data for all dogs and related species. 
Calculation of PIC values from the estimated allelic frequencies was performed 
by use of software developed by our group. The PIC values and HS were calculated for 
several groups of purebreed dogs. 
 
Results 
Eleven microsatellite markers were selected on the basis of ease of resolution of 
products, number and range in size of alleles, and chromosomal location. Seven markers 
could be co-amplified: FH2309, FH2263, FH2293, FH2321 (Mellersh et al. 1997) 
FH2132, FH2137, and FH2001 (Table1) (Francisco et al. 1996). All loci are on different 
chromosomes. Genotype data for the panel of markers were generated for 364 dogs that 
represent 82 breeds recognized by the American Kennel Club, including 16 breeds with 
the highest registration rates in 2002. Breeds not recognized by the American Kennel 
Club included the Boykin Spaniel, Blue Tick Hound, and Long Hair Weimeraner.  
Forty-eight of 364 dogs were mixed breed dogs. Genotype data were also collected for 7 
gray wolves from Alaska, Canada, Sweden, Spain, and Oman, 1 Mexican wolf, 1 red 
wolf, 3 coyotes, representing 3 populations in the United States, 3 species of jackals 
from Africa, 2 New Guinea singing dogs, 1 maned wolf, and 1 African wild dog.  
No 2 genotypes were identical for all 7 microsatellite markers, even among 
closely related individuals. Total heterozygosity and FST were calculated for each marker 
by use of all 383 genotypes. Total heterozygosity ranged from 0.83 to 0.96 with a mean 
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of 0.91 ± 0.04 for all 7 markers. Fixation index ranged from 0.16 to 0.27 with a mean of 
0.19 ± 0.04 (Table 5).  
Polymorphism information content and HS values were calculated for 7 breeds of 
dogs and for the gray wolf (Table 6). Four purebreed groups (Miniature Schnauzer, 
Boxer, Golden Retriever, and Labrador Retriever) were comprised of unrelated, 
randomly selected dogs. Polymorphism information content and HS values for 3 breeds 
(American Eskimo Dog, Dalmatian, and 3 unrelated families of German Shepherd Dog) 
for which extended pedigrees were available, were calculated in these multigenerational 
families. The Miniature Schnauzer, Golden Retriever, and Labrador Retriever groups 
had PIC values similar to published values, which are calculated using 17 reference 
pedigrees of purebred dogs (Mellersh et al. 1997). As expected, PIC values calculated 
within families were generally lower than published values. Among the unrelated 
populations analyzed, the Boxer had the lowest  PIC values for five of the seven 
markers.  
We tested the utility of our multiplexed set of microsatellite markers via 2 
applications of the technique. A breeder of Blue Tick Hounds suspected that 2 males had 
bred a bitch and that the litter of 8 puppies was mixed. Genotype data for the panel of 
markers were collected for the dam, both potential sires, and all puppies. Genotypes for 
FH2137 (Figure 3) and other data revealed that each male sired 4 puppies. Puppies 4 and  
7 had only 1 peak at allele 174 and were homozygous for this locus. Because each parent 
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Table 5.  Microsatellite data  
Marker 
name 
Chromosomal 
Location 
Fluorescent 
Label 
Concentration of 
primer (µmol)  
Range in size 
of alleles (bp) 
No. of 
Alleles 
HT FST 
FH2309 CFA01 VIC 0.60 342 to 474 34 0.93 0.20 
FH2132 CFA02 FAM 0.74 152 to 370 52 0.92 0.27 
FH2137 CFA03 PET 0.30 154 to 316 27 0.90 0.16 
FH2263 CFA09 NED 0.89 175 to 503  50 0.96 0.16 
FH2293 CFA10 VIC 0.74 183 to 527 49 0.91 0.16 
FH2321 CFA17 NED 0.60 276 to 396  42 0.93 0.20 
FH2001 CFA23 FAM 0.45 115 to 163 13 0.83 0.21 
HT = Total heterozygosity 
FST = Fixation index 
 
 
must have contributed 1 of these alleles each, sire 1 can be excluded as the sire of these 
puppies. Puppies 3, 5, and 8 had allele 166, which could only have been contributed by 
the dam. Because the remaining alleles for puppies 3 and 5 were 164 and 174, 
respectively, sire 1 can again be excluded as the sire of these puppies. Puppies 1, 2, 6, 
and 8 had a copy of either allele 162 or 172, excluding sire 2 as the sire of these puppies.  
We also used our set of microsatellite markers to determine the paternity of a 
litter of 4 Miniature Schnauzers. The intended breeding was a repeat breeding, but a 
male from the dams first litter had also bred the dam. Genotype data were collected for 
the dam, both potential sires, and the 4 puppies. Polymorphism information content and 
HS values were calculated within this population (Table 6). Two microsatellite markers, 
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Figure 3. Genotype data for marker FH2137 for 11 Blue Tick Hounds (dam, 2 potential 
sires, and 8 puppies). The number below each peak is the size of the allele 
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FH2293 and FH2321, excluded the dams previous offspring as the sire of 3 puppies and 
1 marker, FH2263, excluded the intended sire as the sire of the fourth puppy. 
 
Discussion 
We developed a single multiplex set of 7 tetra-nucleotide microsatellite markers 
suitable for use in forensic genetic investigations in dogs. Only tetranucleotide 
microsatellite motifs were selected because they are more polymorphic than dinucleotide 
repeats and typically resolve with fewer stutter bands, extra peaks that can result from 
errors during replication and complicate analysis of products (Francisco et al. 1996). The 
polymorphic nature of tetranucleotides is thought to be the result of greater instability 
associated with longer repeat lengths (Francisco et al. 1996). Our data support this 
hypothesis. Of the 7 microsatellite markers, those with the smallest product sizes, 
FH2001 and FH2137, had the lowest number of alleles (13 and 27, respectively). The 
remaining markers had product sizes > 200 nucleotides (with the exception of the maned 
wolf, which has alleles 152 and 160 for FH2132) and a mean of 45 alleles across all 
breeds. FH2001, which had the fewest alleles overall and was the only marker to have all 
alleles differ by exactly 4 nucleotides, was the only (GATA) repeat microsatellite. The 
other 6 markers were (GAAA) repeats known to be markedly polymorphic 
microsatellites and to have variation within the repeat sequence (Francisco et al. 1996). 
 In general, all dogs and related species had similar ranges of allelic sizes. The 
widest range in size of alleles was in FH2293, for which the maned wolf had the smallest 
allele and the Black-backed jackal had the largest. Marker FH2263 also had a wide range 
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of allelic sizes. For example, many dogs in the American Eskimo Dog family and 7 
unrelated dogs of other breeds had allelic sizes of approximately 500 nucleotides for 
FH2263, with the largest allelic size for this marker in the remaining breeds being 275 
nucleotides. Sequence data confirmed that these large alleles were composed of (GAAA) 
repeats. 
Many breeds were represented by a small number of dogs. Therefore, PIC values 
were not calculated for every breed. Total heterozygosity and FST were calculated for 
each marker across all dog breeds and species as measures of genetic variation. The mean 
FST among the microsatellite markers (0.19) lies between 0.15 and 0.25, indicating 
marked genetic differentiation among subpopulations (Liu 1998). Values for humans are 
in the range of 0.02 to 0.11 (Liu 1998). 
The PIC values and allelic sizes in 7 unrelated wolves were similar to those in 
dogs. The similarity of alleles between species indicates that this panel of markers is not 
appropriate for use in evolutionary studies. However, the high PIC values in the wolf and 
the high HS values for the markers indicate that the panel is suitable for forensics 
applications in this species.   
Although the large number of alleles that exist for each marker indicates that the 
panel is highly polymorphic, it is not an indicator of how polymorphic the markers are 
within individual breeds. The PIC values calculated for the Miniature Schnauzers, 
Labrador Retrievers, and Golden Retrievers were similar to published PIC values and 
indicate that these markers are informative within these breeds (Mellersh et al. 1997). 
Only the PIC values for the Boxer were lower than published values (Mellersh et al. 
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1997). This was a factor in selecting the Boxer to be the first breed of dog to have its 
genome sequenced (http://www.genome.gov/11007358). 
Empirically, genetic variability in populations of related dogs will be lower than 
in populations of unrelated dogs (Sutton et al. 1998). Overall, the PIC values calculated 
in the American Eskimo Dog, Dalmatian, and German Shepherd Dog families were lower 
than those of dogs in unrelated populations. Despite a lesser degree of polymorphism, 
sufficient markers are informative (i.e., those with PIC values ≥ 0.5) to identify every dog 
analyzed. 
The 7 selected microsatellite markers were sufficient to determine parentage. In 
the mixed litter of Blue Tick Hounds, all markers supported the conclusion that each 
male sired 4 puppies. One marker (FH2137) was sufficiently polymorphic to reveal the 
paternity of each puppy. The testing involving the Miniature Schnauzers illustrated the 
ability of the 7 microsatellite markers to identify parentage in closely related individuals.  
Despite the lower PIC values in this family of Miniature Schnauzers, compared with 
values for unrelated Miniature Schnauzers, the panel of markers was able to detect the 
paternity of all 4 puppies. 
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CHAPTER V 
CHROMOSOME-SPECIFIC MICROSATELLITE MULTIPLEX SETS FOR 
LINKAGE STUDIES IN THE DOMESTIC DOG 
 
Overview 
To expedite linkage studies and positional cloning efforts in the dog, the MSS-2 
of 327 canine microsatellite markers has been multiplexed into chromosome-specific 
panels. MSS-2 provides 9 Mb coverage of the canine genome with no gaps larger than 
17.1 Mb and is the most recent and comprehensive set of microsatellites available for 
whole genome scans. Markers were labeled with fluorescent dyes based on locations and 
expected product sizes to facilitate the multiplexing of a maximum number of markers 
for each chromosome. All markers are amplified using a single thermal cycling program 
and PCR mix and are optimized for resolution on an ABI 3100 Genetic Analyzer. 
Seventy chromosome-specific panels were created by co-amplification of a maximum 
number of markers and subsequent co-loading of the remaining markers.  
 
Introduction 
Studies of the dog offer insight into the genetic basis for many hereditary 
diseases affecting both canine and human populations (Ostrander and Kruglyak 2000; 
Ostrander et al. 2000; Patterson 2000). Linkage analyses and linkage disequilibrium 
studies are useful for eventual identification of mutated alleles in the dog, many breeds 
of which are characterized by small founding populations, high degrees of inbreeding, 
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and popular sire effects.  The creation and maintenance of multigenerational pedigrees 
offers additional advantages as compared to studies using human populations. To 
facilitate linkage mapping and positional cloning studies in the dog, it is necessary to 
have a defined set of polymorphic markers that provides complete coverage of the 
genome. 
Previously, we multiplexed MSS-1, a set of 172 microsatellite markers (Richman 
et al. 2001) selected from a map comprised of 600 markers (Mellersh et al. 2000) into 69 
reactions, thereby reducing the time, expense, and DNA required for whole genome 
screens (Cargill et al. 2002). The most recent version of the canine map has 3,270 
markers, including 1,596 microsatellite markers (Guyon et al. 2003). From this, a 
superior screening set of microsatellite markers providing increased density and a greater 
level of informativeness was developed. MSS-2 is comprised of 327 microsatellite 
markers that have an average spacing of 9 Mb with no gaps larger than 17.1 Mb (Guyon 
et al. 2003). The set includes 171 tetra-, 151 di-, and 3 tri-nucleotide repeats with an 
average heterozygosity value of 0.73 when analyzed on a panel of unrelated purebred 
dogs.    
 In the human, chromosome-specific multiplexed microsatellite sets have been 
developed to accelerate collection and analysis of data for linkage studies (Reed et al. 
1994; Lindqvist et al. 1996). However, no such sets exist for the dog. The development 
of chromosome-specific multiplex panels will allow rapid screening of those 
chromosomes presumed to harbor genes of interest as determined through comparative 
mapping and genomic sequencing. 
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Materials and methods 
Primer pairs were synthesized by Applied Biosystems (PE Biosystems, Foster 
City, CA) and forward primers were labeled with one of four fluorescent dyes: 6FAM, 
NED, PET, VIC. Previously multiplexed microsatellites (Cargill et al. 2002) that were 
labeled with 6FAM were not relabeled, and those labeled with TET and HEX were 
relabeled with VIC and NED, respectively, to retain their original dye colors. Dye types 
for new markers were chosen for even distribution across each chromosome and size 
range. Primers were diluted to 10 µmol. The primer sequences and intermarker distances 
are available at www.fhcrc.org/science/dog_genome/guyon2003/guyon_data/mss2.html 
and http://www-recomgen.univ-rennes1.fr/doggy.html. 
  All multiplex sets were amplified with a single stepdown thermal cycling 
program: 5 minutes at 95°C followed by 5 cycles of 30 seconds at 95°C, 15 seconds at 
58°C, and 10 seconds at 72°C, and an additional 30 cycles of 20 seconds at 95°C, 15 
seconds at 56°C, and 10 sec at 72°C, with a final extension of 5 minutes at 72°C. A 
single mastermix, excluding primers, was used for all multiplex and individual reactions. 
Concentrations are 0.0045 units/µl Taq DNA polymerase with 0.67X Buffer B (Fisher 
Scientific, Pittsburgh, PA), 4.5 mM MgCl2, 0.67X MasterAmp PCR Enhancer 
(Epicentre Technologies, Madison, WI), 0.75 mM total dNTPs, and 2.8 µl water to bring 
the final mastermix volume to 6.65 µl. One µl of 50 ng/µl genomic DNA was used in 
each reaction. Primer volumes vary by multiplex (Table 7) resulting in different total 
reaction volumes and concentrations. 
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Table 7: Chromosome-specific panels for the MSS-2, listed by multiplex namea followed by marker nameb, primer amountd, and 
fluorescent labele 
1.1 FH3413 0.8 P REN112I02 0.8 V C01.424 0.8 F C00901 0.8 P FH2793 0.6 P FH2326 1.0 N    
1.2 FH3325 0.8 P FH3300 0.8 N C01.251 0.8 N FH2309 0.8 V REN143K19 0.6 V       
1.3 FH2663 1.1 F FH3603 1.5 F FH3922 1.1 F FH2294 0.3 N          
2.1 FH3210 0.8 P REN303H07 0.8 V REN70M14 0.8 V FH3965 0.8 F          
2.2 FH2890 0.4 N C02.609 0.6 P FH2613 0.6 V FH2132 0.6 F          
2.3 FH2274 0.8 N FH2608 0.8 P C02.342 0.8 F             
3.1 REN161A12 0.6 F FH3252 0.6 P FH3464 0.6 V FH2316C 0.8 N FH3377 0.6 N       
3.2 FH3115 0.8 N C03.629 1.2 V FH2145 0.8 P REN260I04 0.6 F          
3.3 FH3396 1 F FH2302 0.6 V                
4.1 REN298N18 0.4 P REN303C04 0.4 V FH2732 0.8 F FH3310 0.8 F REN74B13 0.6 V AHT103 0.8 F    
4.2 FH2776 1.0 P REN195B08 0.8 N FH2097 0.6 N G07704 0.6 V          
5.1 FH3004 0.8 F DTR05.8 0.8 N FH3978 1.0 P REN175P10 0.6 V CPH14C 0.8 N       
5.2 FH3928 0.8 P FH3320 0.6 N FH3702 0.8 F FH3089 0.8 V          
5.3 FH2140 0.8 P REN285I23C 0.8 V FH3278 0.8 P C05.771 0.6 V          
6.1 FH2525 0.8 V FH2561 1.4 N FH2734  0.8 V FH2164C 0.8 V FH3303 0.5 P       
6.2 FH2576 0.6 F FH3933 0.8 P FH2370 0.8 N             
6.3 REN285H12 0.8 F FH2119 0.8 N REN111L07 0.8 P             
7.1 REN97M11 0.8 P FH3972 0.6 N REN162C04 0.8 V REN143L20 0.6 P FH2860 0.4 V       
7.2 FH2226 0.8 N VIASD10 0.8 P FH2973 0.8 P             
8.1 FH3241 0.8 P REN204K13 0.8 N FH3316 0.8 V C08.618 0.8 F          
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Table 7: Continued 
8.2 FH3425 0.8 N C08.410 0.8 F REN178J05 0.6 F FH2989 1.0 V          
9.1 GALK1 0.6 V FH2263 0.8 N C09.173 0.4 N REN54L20 0.4 F G06401 0.6 P REN287G01 0.6 N    
9.2 FH2186 1.4 V REN145P07 0.6 P FH3835 0.3 F REN73K24 0.3 V FH2885 0.4 N       
10.1 FH2537 0.8 N FH4081 0.8 P C10.781 0.6 V ZUBECA1 0.4 N DTR10.5 0.8 F FH3381C 0.8 P    
10.2 REN06H21 0.8 P FH2293 0.8 V C10.16 0.8 F FH2422 0.8 N          
11.1 FH3203 0.8 V REN242K04 0.8 F FH2004 0.6 F C11.868 0.8 P C11.873 0.8 V DGN13 0.8 V    
11.2 AHT137 0.3 V FH4031 0.8 P FH2319 1.0 N FH2019 0.2 N          
12.1 REN153O12 0.6 F FH2401 0.6 V FH3591 0.6 N G01811 0.6 P REN94K11 0.6 N       
12.2 REN258L11 0.8 P REN213F01 0.8 F FH3711C 0.8 N FH1040 0.6 V FH3748 0.8 P       
13.1 C13.391 0.8 N REN120P21 0.6 F FH3619 0.6 P DTR13.6 0.6 F FH2348 1.2 V FH3800 0.6 N    
13.2 FH3494 0.8 V REN227M12 0.8 P                
14.1 FH3951 1 F FH3725 0.6 P FH2658 1 P FH2763 0.4 N          
14.2 C14.866 0.8 F FH3285 0.8 P PEZ10 0.8 V             
15.1 FH4012 0.6 P FH3813 0.8 V FH2171 0.6 N CPH4 0.8 N REN230G12 0.6 F       
15.2 FH3802 0.6 V REN06C11 0.6 F FH2360 0.8 P             
16.1 REN214L11 0.4 V FH2670 0.6 F REN73O19 0.6 P REN85N14 0.8 P FH3592 0.8 V       
16.2 FH2155 1.0 N REN275L19 0.4 N FH2175 1.2 F             
17.1 REN240A05 0.6 F FH3369 0.6 P REN294E18 0.6 V FH3995 0.8 F          
17.2 FH3047 0.8 P FH4023 0.8 P PEZ8 1.0 N FH2869 0.6 V          
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Table 7: Continued 
               
18.1 FH4060 1.0 N FH3944C 0.8 P FH3824 0.4 V FH3815 0.4 F REN54P11C 0.8 P FH2834 0.4 N REN47J11C 0.8 V
 AHT130 0.6 F                   
19.1 REN213G21 0.6 V FH3491 0.4 F FH3313 1.0 P FH2206C 0.8 P FH2380 0.6 N       
19.2 FH3299 0.6 V FH3834 0.6 F FH3969 0.6 N             
20.1 PEZ19 0.8 N FH2951 0.6 F FH2158 1.0 P REN114M19 0.4 F          
20.2 REN55P21C 0.8 N REN100J13 0.8 P REN93E07 0.2 V AHTk209 1.0 N          
21.1 FH3803 1.0 P FH2233CA 0.8 F REN118B15 0.3 V FH2441 0.8 N REN37A15 0.3 V FH3398 0.8 P FH2312CA 0.8 N
22.1 REN42F10 0.8 V FH3355 0.8 V FH3411 0.8 N FH3853 0.8 P          
22.2 REN49F22 1.0 N REN128E21 1.0 P C22.279 0.4 V REN78I16 0.6 F          
23.1 FH3078 0.8 P FH2508 1.0 P FH2626 0.8 F REN113M13 0.6 V REN02P03 0.8 N REN181K04 0.8 P    
24.1 FH3023 0.8 P FH2261C 0.8 F AHT125 0.8 P FH3287 0.8 F REN228J19 0.8 V       
24.2 FH3750 0.8 P FH2159 0.8 N REN106I06 0.6 V REN272I16 0.4 F          
25.1 REN54E19 0.8 F FH3245C 0.8 P FH2324 0.3 N FH2141 1.0 N FH3627 0.3 V FH4027 0.7 F    
26.1 REN62M06 0.4 N DTR26.9 0.4 V FH3426 0.4 V DGN10C 0.8 P FH2130 1.0 N C26.733 0.6 F    
27.1 FH3221 0.8 P PEZ6 0.6 F REN181L14 0.4 N REN72K15 0.4 V          
27.2 FH2289 0.8 P PEZ16 0.3 N LEI002 0.3 F FH3924 0.6 V          
28.1 C28.176 0.8 V FH3963 0.8 P FH2585 0.8 F REN146G17 0.8 V FH2208C 0.8 N       
29.1 FH2952 0.8 P FH2364C 0.8 F REN52D08 0.4 P REN45F03 0.8 F FH2385 1.0 V FH1007 0.3 V    
30.1 FH3489 0.4 F REN51C16 0.4 P REN248F14CA 0.8 V FH2290 1.0 N FH3632CA 0.8 P FH3053 0.4 F    
31.1 FH2189 0.8 N RVC11 0.6 V REN43H24 0.6 N REN109B10 1.2 P REN110K04C 0.8 P FH2712 0.4 F    
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Table 7: Continued                 
 
32.1 REN244E04 0.3 F CPH2 0.4 V FH2875 0.6 N FH3635 1.0 F FH3236 0.8 N AHT127 0.3 V FH3294C 0.8 P
33.1 FH2790 0.4 F FH3608 0.8 F FH2361 0.3 V REN186B12 0.6 V FH2165C 0.8 N       
34.1 FH3721 0.8 P REN174M24 0.6 F REN243O23 0.8 F REN314H10 0.4 V          
34.2 REN109L16 0.8 N FH2377 0.8 V FH3836 0.8 N             
35.1 FH3570 0.8 F REN282I22 0.4 V REN94K23 0.6 N REN112C08 0.6 P          
36.1 REN106I07 0.8 V FH2611 0.8 P REN179H15 0.8 P FH3865 0.8 V DTR36.3C 0.8 N       
37.1 FH3272 0.8 F H10101 0.8 V REN67C18 0.8 P FH3449 0.8 F FH2532 0.8 N       
38.1 FH2766 0.8 P REN02C20 0.8 F REN164E17 0.8 N             
X.1 FH2916 0.8 F REN101G16 1.0 N D04614 0.8 F REN144O22 0.6 V          
X.2 FH3027 0.8 N FH1020 0.8 F FH2985 0.6 N REN230I20 0.6 V          
X.3 REN130F03 0.8 F FH2584 0.8 N REN75A05 0.8 P             
Y.1 REN197E16 0.8 V REN44K10CA 0.6 F DTRY.13CA 0.4 F REN75H09 0.2 V REN173O16 0.2 P       
aDenoted by chromosome and then multiplex number within chromosome 
bMarker names; C indicates that the marker is amplified individually and co-loaded into the panel; CA indicates that the markers are co-amplified  
then co-loaded into the panel. 
dTotal amount (µl) of primer (forward and reverse) in the multiplex.  
eF=6FAM, P=PET, V=VIC, N=NED 
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Multiplex sets were first established by amplifying markers for each 
chromosome in various combinations. Once the maximum number of co-amplified 
markers was achieved, the remaining markers were amplified individually and co-loaded 
into a multiplex set representing individual chromosomes. Duplex sets were co-loaded 
into other multiplexes on the chromosome, if possible. For ease of genotyping, no 
markers having the same dye type and product sizes less than 50 bp apart were 
multiplexed in a chromosome panel. 
PCR products were diluted 1:20 with water and resolved with an internal size 
standard (GeneScan 500 LIZ, PE Biosystems) using an ABI 3100 capillary-based 
Genetic Analyzer (PE Biosystems). For co-loading, dilutions of 1:10 were made for the 
multiplex and combined with dilutions of 1:20 for the co-loaded marker. Analysis of 
multiplex sets was done using ABI GENESCAN version 3.7 (PE Biosystems). 
 
Results 
Three hundred sixteen microsatellite markers from MSS-2 are resolved in 70 
chromosome-specific panels, providing an average of 1.75 multiplex sets per 
chromosome (Table 7). Two hundred ninety six markers can be co-amplified within the 
chromosome panels. The remaining 20 markers are amplified individually and co-loaded 
into designated panels for resolution in a single capillary. Six markers are co-amplified 
in pairs and are then co-loaded with the appropriate panel. Three markers, FH3245, 
REN51i12, and, FH2239, could not be co-amplified or co-loaded in chromosome-
specific fashion and must be resolved individually. 
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All multiplexed markers are amplified using a single PCR mix and thermal 
cycling program. For multiplexing, 78 primers were labeled with 6-FAM, 82 with VIC, 
82 with NED, and 85 with PET. In multiplexes 7.1, 9.1, 12.2, 23.1, and 37.1, two 
markers with the same dye-type have similar product sizes. Eight markers, REN262G24, 
REN286O18, FH3970, FH2200, REN297D17, FH3939, REN89K14, and FH3399, did 
not amplify or were not able to be genotyped using these parameters and, hence, were 
not incorporated into the chromosome-specific panels described here.  
  
Discussion 
The most comprehensive screening set currently defined for linkage studies in 
the dog is MSS-2, which offers 9 Mb coverage and highly polymorphic markers, 
including 64 markers from the MSS-1. To enhance the utility of MSS-2, we have 
developed chromosome-specific multiplex sets, which expedite whole genome scans in 
the dog and have the potential to exclude candidate genes on a given chromosome. 
Collection of data by chromosome also allows for statistical analysis for individual 
chromosomes to be conducted before the whole genome scan is complete and will 
facilitate confirmation of linkage studies, as well as positional cloning efforts. 
The multiplex sets minimize the expense, time, and genetic material necessary to 
collect genotype information for MSS-2. The number of reactions and runs on a Genetic 
Analyzer are reduced by 68% and 75%, respectively. Collection of data is further 
streamlined through use of a single thermal cycling program and PCR mix. To increase 
the ease with which alleles can be determined, markers having the same dye type and 
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product sizes separated by less than 50 bp were not combined in the same panel. 
However, similar product sizes from markers having the same dye type were observed in 
multiplexes 7.1, 9.1, 12.2, 23.1, and 37.1 and alternate dye-types could be selected to 
eliminate possible genotype error.  
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CHAPTER VI 
LINKAGE ANALYSIS FOR PANCREATIC ACINAR ATROPHY IN THE 
GERMAN SHEPHERD DOG 
 
Overview 
 PAA is a degenerative disease of the exocrine pancreas that occurs in the GSD 
and leads to EPI. We have previously shown that PAA segregates in an autosomal 
recessive fashion in two multigenerational families of GSDs. In an effort to facilitate the 
identification of affected and carrier dogs, we hope to identify a genetic marker that co-
segregates with the disease. To do this, linkage analysis using the MSS-1, a set of 172 
microsatellite markers that provides 10 cM coverage of the canine genome and has been 
multiplexed into 69 reactions, was carried out.  
 Using the aforementioned multigenerational pedigrees and the multiplexed MSS-
1, 30 GSDs were genotyped for 163 microsatellite markers. The markers were labeled 
with fluorescent dyes and were resolved on an ABI 377 Sequencer. LOD (Logarithm of 
the Odds) scores for these markers were generated using the SOLAR (Sequential 
Oligogenic Linkage Analysis Routines) software package. Those markers for which 
there were provocative LOD scores were analyzed on additional pedigree members. 
Unfortunately, there were no LOD scores higher than 3.0, which is considered to be the 
minimum score required to infer linkage.  
 These results suggest that no marker from the MSS-1 is in close enough 
proximity to the causative gene such that linkage could be detected. Further studies 
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using markers providing more complete coverage of the canine genome will be required 
in order to identify a marker that co-segregates with PAA. To that end, future work will 
include use of the MSS-2, which is comprised of 327 microsatellite markers and 
provides 9Mb coverage of the canine genome. 
 
Introduction 
PAA is a disease characterized by the degeneration of acinar cells of the exocrine 
pancreas that leads to EPI and occurs primarily in the GSD (Westermarck et al. 1993). 
Ninety-six percent of affected dogs present with symptoms of EPI by five years of age, 
although many dogs show signs as early as 6 months (Westermarck et al. 1993; Raiha 
and Westermarck 1989). Clinical signs include a ravenous appetite, weight loss, and 
voluminous soft stools (Westermarck et al. 1989). Steatorrhea, borborygmus, 
coprophagia, and polydipsia are also associated with EPI (Raiha and Westermarck 
1989). Diagnosis of PAA is accomplished by the measurement of serum canine trypsin-
like immunoreactivity (cTLI) using a radioimmunoassay, which determines the amount 
of trypsinogen released into the bloodstream from the pancreas (Williams and Batt 
1988). The reference range for this assay is 5.0 µg/L to 35.0 µg/L, and values below 2.5 
µg/L are considered diagnostic for EPI (Williams and Batt 1988). This assay has been 
reported to be 100% sensitive and specific for EPI and thus is an effective diagnostic 
tool (Williams and Batt 1988).  
The prognosis for dogs having PAA is typically good with treatment (Wiberg et 
al. 1998). Expensive enzyme supplements must be administered with each meal for the 
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duration of the animal’s life (Wiberg et al. 1998). However, many dogs with EPI are 
euthanized because owners are unable to afford the enzyme supplements (Hall et al. 
1991, Wiberg et al. 2002). 
To understand inheritance of PAA, we previously assembled two 
multigenerational pedigrees of GSDs segregating the disease (Moeller et al. 2002). 
Clinical data for 75 dogs spanning four generations was collected from the first family, 
and for 40 dogs spanning four generations from the second family. Statistical analyses 
conducted using these two families suggest that a single locus segregating in an 
autosomal recessive fashion causes PAA (Moeller et al. 2002).  
It is difficult for breeders to eliminate PAA from their lines because there are no 
means to identify carrier dogs or affected dogs before the onset of clinical signs. 
Identification of a marker linked with the gene causative for PAA would allow for both 
the early detection of affected dogs, and the identification of carrier dogs. To conduct 
linkage analysis, it is necessary to have a set of markers that are evenly distributed 
across all chromosomes. The MSS-1 is a set of 172 microsatellite markers and is the first 
screening set providing 10 cM coverage of the canine genome (Richman et al. 2001). 
Our group previously multiplexed the MSS-1 into 69 reactions (Cargill et al. 2002).  
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Figure 4. Pedigrees I and II: Subsets from 2 unrelated families of GSDs segregating PAA. 
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Materials and methods 
For each dog included in the analysis, blood and serum were collected by 
veterinarians and submitted for use in the study. Serum samples were submitted to the 
Gastrointestinal Laboratory at Texas A&M University for measurement of cTLI to 
determine the clinical status of each dog. DNA was extracted from 3 ml of whole blood 
using the Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, MN) and 
rehydrated in 250 ul of DNA rehydration solution. To ascertain the quality and quantity 
of DNA, 5 ul of each sample were analyzed by gel electrophoresis and 5 ul were used 
for spectrophotometric analysis.  
Only litters having affected members were included in the screen. For our initial 
linkage screen, 14 dogs from Pedigree I and 12 dogs from Pedigree II were selected 
(Figure 4). Also included were 4 dogs from a smaller, unrelated pedigree. Primers that 
amplify the MSS-1 markers were synthesized and the forward primers were labeled with 
one of three fluorescent dyes, 6FAM, TET, or HEX (PE Biosystems, Foster City, CA). 
Amplification and resolution of microsatellite markers were achieved exactly as 
described in Chapter III. Genotypes were determined using Genotyper 2.0 software and 
each peak was given an integer value (PE Biosystems). 
Once genotypes for all pedigree members were determined for the MSS-1 
markers, a two-point LOD (Logarithm of the Odds) score was calculated for each 
marker. A LOD score is the measurement of the likelihood that the marker is linked with 
the disease. The minimum LOD score necessary to infer linkage is 3.0, which 
corresponds to odds of 1000:1 in favor of linkage. Calculation of LOD scores was 
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completed using the SOLAR (Sequential Oligogenic Linkage Analysis Routines) 
software package. To reduce false negative results, analyses were conducted using both 
binary and quantitative traits, based on the clinical status and the TLI result, 
respectively.  
Because population size is critical in linkage analyses, genotypes for additional 
pedigree members were collected for markers that were informative in the two families. 
Genotype data for these markers were generated for twenty additional dogs from 
Pedigrees I and II (Figure 4) and LOD scores were recalculated. Markers of interest were 
further analyzed using genotype data for all members of the three pedigrees. 
 
Results 
Genotype data for 163 microsatellite markers from the MSS-1 were collected for 
30 GSDs. The remaining nine markers (ZuBeCa6, FH2149, FH2279, FH2346, N41, 
FH2457, AHT006, REN51i12, FH2600) could not be amplified using the reported 
conditions and data were not generated for them. No LOD scores from the initial screen 
indicated linkage. The highest LOD score was 1.3 for REN49C08, a marker on CFA11. 
Further analysis using additional pedigree members eliminated this marker as a 
candidate marker.  
Eighty of the 172 markers had four or more alleles in our families. For these 
markers, PIC values were calculated. The PIC value is a measurement of how 
informative a  marker  is.  A subset  of 63 MSS-1 markers, that  had four or more  alleles 
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Table 8. Chromosomal location and LOD score for 63 MSS-1 markers determined to be 
informative in our families 
Chromosome Marker LOD Chromosome Marker LOD 
CFA01 C01.424 0.00 CFA16 FH2175 0.00 
CFA01 FH2016 0.00 CFA17 PEZ8 0.00 
CFA01 FH2598 0.00 CFA18 AHT130 0.00 
CFA02 FH2087U 0.00 CFA18 WILMS-TF 0.10 
CFA03 FH2137 0.90 CFA19 FH2206 0.00 
CFA03 FH2531 0.43 CFA20 CPH16 0.00 
CFA03 FH2145 0.01 CFA20 FH2528 0.00 
CFA03 FH2107 0.53 CFA21 FH2233 0.00 
CFA03 FH2302 0.32 CFA22 CXX.279 0.00 
CFA04 FH2142 0.00 CFA23 FH2283 0.00 
CFA04 FH2534 0.13 CFA23 FH2227 0.00 
CFA05 FH2594 0.00 CFA24 FH2261 0.00 
CFA05 FH2383 0.00 CFA25 FH2526 0.00 
CFA06 FH2525 0.00 CFA25 FH2141 0.00 
CFA07 FH2301 0.00 CFA27 PEZ6 0.09 
CFA07 FH2581 0.00 CFA28 FH2585 0.00 
CFA07 FH2226 0.00 CFA29 FH2364 0.00 
CFA07 FH2396 0.00 CFA29 REN45F03 0.00 
CFA08 C08.410 0.00 CFA30 1F11 0.00 
CFA09 FH2263 0.00 CFA30 FH2305 0.14 
CFA09 FH2186 0.00 CFA30 FH2290 0.00 
CFA10 FH2293 0.10 CFA31 FH2199 0.41 
CFA10 FH2422 0.04 CFA31 CXX.642 0.03 
CFA10 FH2339 0.14 CFA31 FH2239 0.03 
CFA11 FH2018 0.09 CFA32 FH2238 0.20 
CFA11 FH2319 0.00 CFA33 FH2507 0.00 
CFA12 FH2223 0.14 CFA37 FH2587 0.00 
CFA13 FH2394 0.00 CFA37 FH2532 0.00 
CFA14 FH2547 0.00 CFA38 FH2244 0.00 
CFA15 FH2278 0.00 Unlinked FH2247 0.00 
CFA15 FH2171 0.00 Unlinked PEZ7 0.00 
CFA16 FH2155 0.00    
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and a PIC ≥ 0.55, was determined to be informative in our families.  
No LOD scores calculated for the 63 markers using the additional pedigree 
members were ≥ 3 (Table 8). Four of the five highest LOD scores were from markers 
located on CFA03: FH2137 (0.9), FH2107 (0.53) FH2531 (0.43), and FH2302 (0.32). 
Further analyses of these markers resulted in a reduced LOD score for FH2137 (0.7), but 
an increased score for FH2107 (1.14), FH2531 (0.44), and FH2302 (0.6) (Figure 5).  
 
 
Figure 5. CFA 03: LOD scores for markers which were informative (≥ 4 alleles) in our 
families.  
* marker positions are estimated based on linkage map 
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Only two of these markers were informative in our pedigrees and no LOD scores were ≥ 
3 (Figure 5). 
 
Discussion 
Our results indicate that none of the 163 microsatellite markers analyzed are 
located in close enough proximity to the causative gene for PAA to be useful as a 
genetic marker. The highest LOD scores were identified for markers located on CFA03. 
Analyses will be conducted for additional markers in this region as they are identified. 
 Based on the number of alleles and PIC values, less than 40% of the markers 
analyzed were informative in our families. Although the MSS-1 provides 10cM 
coverage of the canine genome, the limited number of informative markers diminishes 
the coverage actually achieved with our screen. The MSS-2, a screening set of 327 
microsatellite markers providing 9Mb coverage of the canine genome, has recently been 
characterized (Guyon et al. 2003). Now that multiplexing of the MSS-2 has been 
completed, we intend to use this set in a second screen for linkage. We also continue to 
collect pedigree members of the families of GSDs examined here in order to increase the 
power of future screens.  
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CHAPTER VII 
   CONCLUSIONS 
 
Our laboratory’s interest in canine genetics stems from the importance of the dog 
to our society. For thousands of years, dogs have been our protectors, workers, aides, 
and companions. Today, studies in dogs also contribute to our understanding of 
mammalian hereditary diseases (Ostrander and Kruglyak 2000). The goals of the work 
presented here were to 1) develop tools that can accelerate the characterization of genes 
that are involved in hereditary diseases affecting the dog, and 2) determine the mode of 
transmission of PAA in the GSD and identify possible causative genes.  
PAA is one of many diseases of the dog that are inherited in an autosomal 
recessive manner. Roughly two-thirds of hereditary diseases of the dog exhibit 
autosomal recessive inheritance (Ostrander and Kruglyak 2000), and for many of these, 
symptoms are not evident until later in life. Such diseases are particularly frustrating to 
breeders because it is not possible to recognize affected dogs before the onset of 
symptoms or to identify which dogs carry mutations. 
Microsatellites are widely used for the identification of individuals, evolutionary 
studies, and as marker-based tests for hereditary diseases (Leopoldino et al. 2002). The 
identification of microsatellite markers linked with various hereditary diseases provides 
breeders with the necessary tools to identify carrier and affected dogs and reduce the 
incidences of diseases in their breed. Two sets of microsatellite markers providing 
complete coverage of the genome have been described for linkage analysis in the dog 
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(Richman et al. 2001; Guyon et al. 2003). The utility of these sets can be enhanced 
through multiplexing. 
Chapter II reports the assembly of two extended pedigrees of GSDs that 
segregate PAA and the results of statistical analyses conducted using these families 
(Moeller et al. 2002). Other research efforts to understand the genetics of PAA have 
suggested an autosomal recessive mode of inheritance (Weber and Freudiger 1977; 
Westermarck 1980), but no statistical data were collected in these studies. Complex 
segregation analysis revealed that in the two pedigrees described, PAA is caused by a 
single gene segregating in autosomal recessive fashion. 
The development of a set of multiplexed microsatellite markers suitable for 
linkage studies in the dog (Cargill et al. 2002) is described in Chapter III. The MSS-1, 
comprised of 172 microsatellites providing 10cM coverage, is the first set of 
polymorphic markers defined for whole genome screens in the dog (Richman et al. 
2001). The MSS-1 was enhanced by the development of 48 multiplex sets, which 
minimize expenses and time required to collect genotype information by reducing the 
number of reactions by 60%. Primers were labeled with fluorescent dyes (TET, HEX, 
6FAM) and sets of markers that could be co-amplified were identified. More 
specifically, 151 markers could be co-amplified, 4 markers could be co-loaded after 
individual amplification, and 17 were amplified individually. Reactions were optimized 
for resolution on an ABI 377 Genetic Analyzer.  
Chapter IV describes the development and evaluation of a specialized, 
multiplexed set of microsatellite markers for use in canine forensics (Clark et al. 2004). 
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MSS-1 markers with high PIC values were analyzed for significant polymorphism and 
ease of genotyping. A subset of 7 markers that could be co-amplified in a single reaction 
was identified. Genotypes were collected for 85 breeds and 19 other members of family 
Canidae. This marker set is used to determine parentage in closely related dogs. 
Chapter V reports the development of chromosome-specific multiplex panels of 
microsatellite markers for more comprehensive linkage studies in the dog (Clark et al. 
2004). The MSS-2, comprised of 327 microsatellites, is the latest screening set defined 
for linkage analysis in the dog and offers greater coverage (9Mb) and more polymorphic 
markers (Guyon et al. 2003). Primers were labeled with fluorescent dyes (6FAM, VIC®, 
NED®, PET®) based on chromosomal locations, so that multiplex sets could be created 
for each chromosome. Reactions were optimized for resolution on an ABI 3100 Genetic 
Analyzer. Seventy chromosome-specific panels for the MSS-2 were developed, reducing 
the number of reactions by 68% and number of runs on the ABI 3100 by 75%. 
Results from linkage analyses for PAA using the aforementioned pedigrees of 
GSDs are reported in Chapter VI. Genotypes for 30 GSDs were generated for 163 
markers using the multiplexed MSS-1. LOD scores and PIC values were calculated for 
each marker. Twenty additional GSDs were genotyped for 63 markers that were 
informative in our pedigrees. The highest LOD scores were found for markers located on 
CFA03, though none of the scores approached statistical significance. It will be 
necessary to analyze additional GSDs using a more comprehensive set of markers in 
order to identify linkage with PAA. 
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In conclusion, this work provides new tools that will facilitate study of canine 
hereditary diseases and adds to the knowledge concerning transmission genetics of PAA 
in the GSD. To date, linkage of markers with PAA has not been identified. Now that 
multiplexing of the MSS-2 is complete, we intend to use this set to conduct a second 
screen for linkage with PAA using Pedigrees I and II. We also continue to collect 
members of these families in order to increase the power of this screen. Another method 
that we are pursuing to identify candidate genes for PAA is microarrays. We are 
collecting tissue from affected and normal GSDs and will use cDNA isolated from these 
tissues to probe a canine oligonucleotide array to assess differences in gene expression in 
an attempt to identify (1) biomarkers that may help in early diagnosis and (2) potential 
candidate genes that may be causative for PAA. 
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